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ABSTRACT 
Amber Lynn Koenig: Probing the Mechanism of Binding and Recognition of Methylated 
lysine 
(Under the direction of Marcey Waters) 
 
  
 Lysine methylation is an important posttranslational modification that is responsible 
for the proper regulation of gene expression.  The misregulation of these methylation marks 
has been linked to various diseases.  Proteins that are involved in the regulation and 
recognition of these marks are emerging therapeutic targets.  Detailed understanding of the 
mechanism employed by these proteins to recognize their natural substrates would provide 
valuable information for the development of probes with the necessary affinity and 
specificity required to provide activity and avoid off target effects.   
 Cation-π interactions are thought to be one of the major noncovalent interactions 
contributing to methylated lysine recognition.  Here we have demonstrate that two tyrosine 
residues present in the binding pocket of the reader protein heterochromatin protein 1 (HP1) 
show differential contributions to trimethyllysine recognition.  By incorporating unnatural 
amino acids containing substitutions on the aromatic rings, we tune the ability of these 
residues to participate in cation-π interactions, which influences overall binding affinity.  We 
demonstrate a clear linear free energy relationship (LFER) at both tyrosine positions of 
different magnitudes. 
 In order to probe cation-π interactions with tryptophan mutations, we report synthetic 
methods for incorporation of unnatural amino acids that are not amenable to in vivo unnatural 
! iv!
amino acid mutagenesis.  We demonstrate the synthesis of fmoc-protected fluorinated 
tryptophan for use in solid phase peptide synthesis, as well as an improved method for 
synthetically accessing long peptide or short protein sequences.  By acetyl capping after 
coupling steps of solid phase peptide synthesis we have eliminated the possibility of deletion 
products arising from incomplete coupling reactions.  By adding a polyhistidine tag at the N-
terminus, we greatly simplified purification by incorporating an affinity tag that allows the 
isolation of only the fully synthesized protein.  Furthermore, the function of the synthetic 
protein was confirmed by performing a binding assay with its native substrate. 
 Lastly, we discuss ongoing efforts to expand studies to other reader proteins, as well 
as other substrates, including dimethyllysine, inhibitors, and a neutral analog.  By studying 
other proteins that contain different binding pockets, such as lower methylation state readers 
that incorporate salt bridges, we can develop a broader and more complete understanding of 
the mechanism of recognition of these post-translational modifications.  This information not 
only provides information for therapeutic design, but a fully characterized system for 
studying cation-π interactions can be a useful system for testing computational methods 
aimed at modeling these binding interactions for medicinal chemistry purposes. 
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CHAPTER 1: RECOGNITION OF METHYLATED LYSINE AND CATION-Π 
INTERACTIONS 
 
1.1 Purpose of this work 
 With the emergence of trimethyllysine reader proteins becoming important 
therapeutic targets, an in depth understanding of their mechanism of recognition of their 
substrates will be advantageous to drug design.  Information on the contribution of each 
residue to the binding interaction, as well as a broad comparison of reader proteins with 
different binding pockets can guide the design of inhibitors or probes for broad classes of 
reader proteins, as well as specific readers.  While there have been some identified 
inhibitors of these proteins, it remains unknown whether they bind by the same cation-π 
mechanism as the natural substrate, or by an alternative mechanism.   
 The purpose of this work is to further probe reader protein binding mechanisms to 
provide a detailed understanding of the nature of these cation-π interactions.  A 
systematic protein structure activity relationship (protein SAR) study, by systematically 
altering the binding pocket of reader proteins is used to provide a detailed description on 
the balance of forces in the binding of trimethyllysine.   
1.2. Epigenetics 
The human body consists of trillions of cells, all of which are genetically 
identical.1  Despite containing identical DNA sequences, our cells are highly 
differentiated and specialized for diverse and specific functions.  Cells with the same 
genotypes can show different phenotypes.2 Therefore mechanisms must be in place that 
!! 2 
control and regulate gene expression in order to produce the diverse sets of phenotypes 
possible using the same genomic sequence.  As a result, the field of epigenetics, the study 
of these differences in gene expression without differences in the nucleic acid sequence, 
has become increasingly popular.3  Moreover, the mechanism for regulating gene 
expression and silencing has risen in importance from a therapeutic standpoint, as the 
misregulation of expression is implicated in many diseases.4   
1.2.1 Chromatin Structure 
The extent of DNA packaging is responsible for whether or not a gene is 
accessible and active or if it is silenced.5  In order to condense the large amount of DNA 
that must fit within the nucleus, the DNA is highly condensed into chromatin.  One copy 
of the DNA in the human genome, fully stretched out, would measure over two meters in 
length, while the nucleus of our cell is only about 10 µM in diameter.6  About 147 base 
pairs of the DNA strand is wrapped around eight histone proteins forming a nucleosome 
(Figure 1.1).  These nucleosomes are further compacted together into chromatin.6  There 
are two different types of chromatin.  Heterochromatin is tightly compacted and genes 
present in heterochromatin are inaccessible and silenced, while euchromatin is more 
loosely packaged and active (Figure 1.2).5 
!! 3 
 
 
ﬁber for which several models have been created based on
experimental data using cryogenic-electron microscopy (cryo-
EM) and X-ray crystallography.8
This review focuses on recent advances in our understanding
of the structure and function of the nucleosome and is divided
into four parts. First, we present a primer covering the
fundamentals of the nucleosome core particle structure
determined at atomic scale by X-ray crystallography in 1997.9
Next we discuss recent insights into the role of DNA sequence
in the structure of nucleosomal DNA based on structure−
function studies of nucleosome core particles containing
derivatives of the Widom 601 nucleosome positioning
sequence.10 We then introduce patterns of nucleosome
recognition by chromatin factors using recent crystal structures
and NMR and cryo-EM models of peptide and protein
macromolecular chromatin factors bound to the nucleosome
core particle. Finally, we will compare a recent cryo-EM model
for the 30 nm chromatin ﬁber11 to two previous models based
on crystallographic and cryo-EM data.12,13
2. FUNDAMENTALS OF THE NUCLEOSOME CORE
PARTICLE STRUCTURE
While the composition of the nucleosome had long since been
realized, the 1997 2.8 Å crystal structure of the nucleosome
core particle (NCP) solved by Luger et al. aﬀorded the ﬁrst
atomic depiction of this fundamental genomic unit.9 This
structure showed 146 bp of the human alpha-satellite sequence
wrapped 1.65 times around an octameric scaﬀold of Xenopus
laevis histone proteins in a left-handed superhelix (Figure 1a). A
single base pair is centered on the nucleosome dyad,14 which
deﬁnes the pseudo-2-fold symmetry axis of the NCP. DNA
locations are designated by superhelical locations (SHL)
representing superhelical turns from the dyad (SHL 0) and
ranging from SHL −7 to SHL 7. The central histone octamer
contains two copies of each of the core histone proteins, H2A,
H2B, H3, and H4 as established by Arents and Moudrianakis in
the 1991 3.1 Å crystal structure of the histone octamer.15 The
core histones are assembled into four histone-fold heterodimers
(two each of H2A/H2B and H3/H4). Ten ﬂexible tails
protrude from the NCP at deﬁned locations, one N-terminal
tail from each of the eight core histone proteins and two
additional C-terminal tails contributed by H2A.
2.1. Histone-Fold Heterodimers
Each of the core histones contains a central α-helical region
that forms a histone-fold motif, ﬂanked by N- and C-terminal
extensions. The histone-fold is constructed from three α helices
connected by two intervening loops speciﬁed as α1-L1-α2-L2-
α3 (Figure 1b,c).9,15,16 The two shorter α1 and α3 helices loop
back to pack against the longer central α2 helix. Each histone-
fold pairs with a complementary histone-fold, H3 pairs with H4
and H2A pairs with H2B, to form a histone-fold heterodimer
handshake motif. The antiparallel arrangement of this
heterodimer approximates the L1 loop from one histone-fold
and the L2 loop of the complementary histone-fold, placing
one L1L2 pair at each end of the heterodimer. The result is a
crescent-shaped heterodimer with the convex surface including
the L1L2 loops and the α1 helices and the concave surface
including the α3 and central α2 helices. The convex surface of
the H2A/H2B and H3/H4 heterodimers carries a strong
positive charge and constitutes the primary DNA binding
element of each histone-fold heterodimer.
Figure 1. Nucleosome core particle structure and the histone-fold heterodimers. (a) Nucleosome core particle structure (PDB ID 1KX5). Histones
and DNA are depicted in cartoon and sticks representations, respectively, and colored as indicated. (b) H3/H4 histone-fold heterodimer. (c) H2A/
H2B histone-fold heterodimer. Structures (top) and schemes (bottom) with secondary structure elements indicated. All molecular graphics in this
review were prepared using PyMOL software (The PyMOL Molecular Graphics System, version 1.6, Schrodinger, LLC). All structures of NCP using
high-resolution structure17 (PDB ID 1KX5) unless indicated otherwise.
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Figure 1.1. Crystal structure of DNA wrapped around histone protein octamer forming 
a nucleosome with tails extending outward.6 Reprinted with permission from Chem. 
Rev. 2015, 115, 2255- 2273. Copyright 2015 American Chemical Society.  
 
Figure 1.2. Active euchromatin (left) and inactive heterochromatin (right), with 
representative modifications often seen on each.5 From Science, 2001, 293, 1074-
1080. Reprinted with permission from AAAS.  
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 histone tails would induce interaction affini-
 ties for chromatin-associated proteins, and
 (ii) modifications on the same or different
 histone tails may be interdependent and gen-
 erate various combinations on any one nu-
 cleosome.
 Here, we wish to extend this concept for
 overall chromosome structure by proposing that
 (iii) distinct qualities of higher order chromatin,
 such as euchromatic or heterochromatic do-
 mains (7), are largely dependent on the local
 concentration and combination of differentially
 modified nucleosomes (Fig. 1A). We envision
 that this "nucleosome code" then permits the
 assembly of different epigenetic states (7),
 leading to distinct "readouts" of the genetic
 information, such as gene activation versus
 gene silencing or, more globally, cell prolifer-
 ation versus cell differentiation. Any such mod-
 el must account for how these epigenetic states
 are established, maintained, and stably inherited
 through mitosis and meiosis. Although there is
 clear evidence for a "cellular memory" (8),
 sudden switches in cell fate do occur, leading to
 variegating phenotypes. If the histone code hy-
 pothesis is correct, at least in part, deciphering
 how that code is translated into biological re-
 sponse remains an important and nontrivial
 challenge. On the basis of current knowledge,
 other possibilities are likely to exist, including
 less stringent "charge patches" in histone tails
 (9).
 Clear evidence is beginning to link alter-
 ations in chromatin structure to cell cycle
 progression, DNA replication, DNA damage
 and its repair, recombination, and overall
 chromosome stability (10). It also seems like-
 ly that the fundamental nature of chromatin-
 based epigenetics will have an impact on X
 inactivation, imprinting, developmental re-
 programming of cell lineages, and the plas-
 ticity of stem cells. The implications for hu-
 man biology and disease, including cancer
 and aging, are far-reaching.
 Su(var)s, Histone Methylation, and
 Heterochromatin
 It is now widely recognized that heritable, but
 reversible, changes in gene expression can
 occur without alterations in DNA sequence.
 Pioneering studies on radiation-induced chro-
 mosomal translocations (11) provided some
 of the earliest findings that epigenetic "on-
 off" transcriptional states are largely depen-
 dent on the position of a gene within an
 accessible (euchromatic) or an inaccessible
 (heterochromatic) chromatin environment.
 This phenomenon, known as position-effect
 variegation (PEV), allowed the development
 of genetic screens in Drosophila (12) and S.
 pombe (13, 14) that have identified -30 to
 40 loci involved in modifying PEV. Similar
 to PEV, mating-type switching in budding
 (15) and fission (16) yeast represents another
 paradigm for a variegating mechanism where
 the location of a gene within a distinct chro-
 matin environment, the mat region, dictates
 the establishment of an active or a silent
 transcriptional state. In particular for S.
 pombe, which appears to contain a higher
 order chromatin structure more closely re-
 sembling that of multicellular eukaryotes, in-
 heritance of silenced chromatin domains has
 been shown to be remarkably stable during
 both mitosis and meiosis (16).
 A euchromatin heterochromatin
 B
 E1 E(var) HT - Su(var)
 ON/ OFF/
 active IJ* J iL sile ced
 FEU - Su(var) HET] ----' E(var)
 v , proteolysis ?
 C active/accessible inactive/conde sed
 [H3] ARTKQTARKSTGGKAPRKQL [H3] ARTKQTA RKSTGGKAPRKQL
 910 14 10
 [CENP-A] MGPRRRSRKPEAPRRRSPSP
 7
 [H3] ARTKQTARKSTGGKAPRKQL
 4 14 4
 t e> [H3] ARTKQTARKSTI IGKAPRKQL 9
 [H4] SGRGKGGKGLGKGGAKRHRK [H4] SGRGKGGKGLGKGGAKRHRK
3 5 12
 D "0 Fig. 1. Models for euchromatic or hetero-
 A chromatic histone tail modifications. (A)
 ';| y^\^\~,~~ >Schematic representation of euchromatin
 and heterochromatin as accessible or
 condensed nucleosome fibers containing
 I + \ 'acetylated (Ac), phosphorylated (P), and
 ARTKQT ARKSTGGKAPRKQL...histone H3 methylated (Me) histone NH2-termini.
 ~~~~~~4 910 14 ~(B) Generic model for antagonistic E(var)
 ^"Yf7~~~~~~~ ^\ and Su(var) gene function in adding eu-
 ~9 '^ a~ t . 9 chromatic (EU) or heterochromatic (HET)
 * ~ 24 VSC~)0B *' ~ modification marks onto a nucleosomal
 "^'pa/ c Y -template. In addition, Su(var)s also func-
 sGRGKGGKGLGKGGAKRHRK...histone H4 tion in removing euchromatic signals and
 3 5 16 18 20 E(var)s can destabilize the heterochro-
 matic state. (C) Examples of combinato-
 rial modifications in histone NH2-termini
 that are likely to represent "imprints" for active or inactive chromatin. Single-letter abbreviations
 for amino acid residues: A, Ala; E, Glu; G, Gly; H, His; K, Lys; L, Leu; M, Met; P, Pro; Q, Gin; R, Arg;
 S, Ser; and T, Thr. (D) Proposed synergistic (connected arrowheads) or antagonistic (blocked oval
 line) modifications in histone H3 and H4 NH2-termini. The arrow with the scissors indicates
 possible proteolytic cleavage of the H3 NH2-terminus.
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1.2.2 Posttranslational Modifications (PTMs) 
The formation of heterochromatin and euchromatin is controlled by a complex 
series of posttranslational modifications (PTMs) on the histone proteins.  PTMs are 
covalent modifications on the side chains of amino acids that are installed after the 
protein has been translated from RNA (Figure 1.3).  Common examples of these 
modifications include methylation of lysine (mono, di, and tri), methylation of arginine 
(mono and di – either symmetrically or asymmetrically), acetylation of lysine, and 
phosphorylation of serine, threonine, and tyrosine. 
 
These modifications are found on histone proteins – most abundantly on the 
unstructured tail regions on the histone N-terminus. The nucleosome consists of an 
octomer of histone proteins, containing two each of histone proteins H2A, H2B, H3 and 
H4, while H1 links adjacent nucleosomes.6  Posttranslational modifications marks are 
regulated and recognized by proteins known as “writers,” “readers,” and “erasers.”  
Posttranslational modifications work in tandem with one another to form what has been 
Figure 1.3. Various methylation states of lysine (top) and arginine (bottom) 
Arginine can be methylated symmetrically (sRMe2) or asymmetrically 
(aRMe2).   
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!! 5 
termed the “histone code.”5  The modifications regulate chromatin formation both by 
altering interactions with DNA and between nucleosomes, as well as recruiting other 
proteins and enzymes involved in chromatin remodeling.7  They can also work together 
in the regulation of other modifications, known as histone “cross talk.”8 
1.3 Lysine methylation 
Lysine methylation, while one of the most common posttranslational 
modifications, has not been extensively studied until recent years.  Unlike acetylation and 
phosphorylation, which change the charge of the side chain, lysine methylation maintains 
the same overall side chain charge.  Methylation is site-specific and the different levels 
(mono, di, and trimethylation) can effect gene expression differently, leading to added 
complexity with methylation compared to other posttranslational modifications.  There 
have been various assays developed to map out the methylation pattern and determine the 
proteins that recognize these specific marks.  The most characterized histone tail in terms 
of PTM’s has been the H3 tail.  There are at least 4 lysine positions that can be 
methylated on the H3 tail (K4, K9, K27, and K36).9  The regulation of these marks are 
important for cell cycle regulation, DNA damage response, and development and 
differentiation.10 
The location of these modifications within chromatin are important for proper 
regulation of gene expression, however determining how specific enzymes are recruited 
to certain histones is an active area of research. Studies have identified several DNA 
sequences found to recruit certain modifying enzymes to target areas.10The proper levels 
and activities of these enzymes and reader proteins are important in maintaining proper 
chromatin state and gene expression. 
!! 6 
1.3.1 Writers: Lysine Methyltransferases 
 The first histone lysine methyltransferase (HKMT) to be discovered was 
SUV39H1, which methylates H3K9.11  The vast majority of HKMTs contain a domain 
known as the SET domain (derived from the proteins it was identified in: Drosophila 
Su(var)3-9 and ‘Enhancer of zeste’ proteins).12  These enzymes catalyze the transfer of a 
methyl group from S-adenosylmethionine (SAM) to the amino group of the lysine side 
chain (Figure 1.4).  Most of these enzymes are very specific for a single site on a histone 
tail, and can modify the ammonium to specific degree of methylation (mono-, di-, or tri-).  
Often times this selectivity for methylation states is caused by a specific amino acid in 
the active site of the enzyme.7 For example, one enzyme that can form trimethyllysine 
(DIM5), contains a phenylalanine in the active site.13,14  Another enzyme, SET7/9, 
contains  the slightly larger tyrosine residue, and can only accommodate the monomethyl 
product.15  This dependence on phenylalanine or tyrosine to control the degree of 
methylation is thought to be general to these SET domain enzymes.16,17 
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Figure 1.4. Mechanism of SET7/9 (blue) methylation of lysine (green) with 
cofactor SAM (red), to form monomethyllysine and S-adenosylhomocysteine 
(SAH).15 
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1.3.2 Erasers: Lysine Demethylases 
It was initially believed that lysine methylation was a permanent mark, and there 
were no mechanisms for removal.7  In 2004, the first lysine demethylase (LSD1) was 
discovered, which led to the conclusion that lysine methylation is a dynamic process.18  
This enzyme, however, requires a protonated nitrogen in order to function, and thus, 
cannot demethylate trimethyllysine.  Another class of enzymes that contain a catalytic 
jumonji domain was discovered in 2006, which was capable of demethylating 
trimethyllysine.19  These enzymes utilize a radical mechanism for demethylation of 
trimethyllysine.  Histone methylation, while reversible, has a lower turnover rate than 
some other modifications.  Furthermore, some sites need to be maintained, and different 
sites have different rates of turnover.10   
1.3.3 Readers Proteins 
Reader proteins are proteins that specifically recognize certain epigenetic marks 
leading to gene expression, gene silencing, or regulation of other modifications.10 Some  
methyl binding domains commonly involved in the recognition of these marks include 
PHD, WD40, CW, and PWWP domains, as well as the “royal family” which includes 
tudor, chromo, MBT domains.20  As the level of methylation increases, the number of 
hydrogen bond donors on the sidechain decreases (with trimethyllysine unable to form a 
hydrogen bond), and the size and hydrophobicity increase.  This allows for the specific 
recognition of different methylation states.20   
There are two primary modes that reader proteins typically employ in order to 
bind to methylated lysine (Figure 1.5).  In a cavity insertion recognition mode, such as 
that found in 53BP1 tandem tudor domains,21 the methylated lysine is buried deep into a 
!! 8 
protein cavity.  This mode is often present with readers of lower methylation states, and 
may also provide a way of discrimination of different states based on size.20  Proteins that 
act via a surface groove recognition mode have a binding pocket that is more accessible, 
providing slightly less specificity for methylation states. Domains that recognize 
methylated lysine contain an “aromatic box” consisting of 2-4 aromatic residues that bind 
to the cation, presumably via cation-π interactions, as described below.22 
!!! 
1.4 Cation-π Interactions 
Cation-π interactions are prevalent across various biological systems are  
particularly involved in protein-protein interactions and protein folding.23  While other 
intramolecular interactions such as salt bridges, hydrogen bonding, and the hydrophobic 
effect have been known and well studied in biological systems, advances demonstrating 
the prevalence of cation-π interactions has been more recent.23,24   
 
 
Figure 1.5.  Depiction cavity insertion recognition (left), surface groove 
recognition (center) and aromatic box motif (right). Reprinted by permission 
from Macmillan Publishers Ltd: Nat. Struct. Mol. Biol., 2007, 14, 11, 1025-
1040., Copyright 2007. 
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1.4.1 Description of Cation-π Interactions 
Cation-π interactions are an electrostatic interaction between a positively charged 
cation and the partial negative face of an aromatic ring, arising from the quadrupole 
moment.23  The dipole between the hydrogen atoms and the sp2 hybridized carbon atoms 
in the ring create the quadrupole moment of aromatic compounds.  While these 
interactions are commonly seen in aromatic rings, the aromaticity is not necessary for the 
electrostatic interaction. 25 
These interactions were first seen in gas phase experiments where it was observed 
that the interaction between metal cations with benzene was stronger than their 
interaction with water.  The ΔH of the interaction between potassium ions and benzene, 
for example, was -19.2 kcal/mol, while the interaction between potassium and water was 
-17.9 kcal/mol.26 Trimethylamonium cations also exhibited a difference with a delta H of 
9.4 kcal/mol with benzene and 9.0 kcal/mol with water.27  The cation-π interaction 
between these metal cations and benzene follow the traditional electrostatic model with 
Li+>Na+>K+>Rb+.26,28–30  
While these initial observations were all in the gas phase, the cation-π interaction 
is also favorable in aqueous systems.  Unlike amino acids that form salt-bridges and 
hydrogen bonds, which are often well solvated and prefer to interact with water than each 
other, the additional driving force for this interaction, which also includes van der Waals 
interactions and the hydrophobic effect, make cation-π interactions favorable even in 
aqueous systems, with countless examples in biological systems.24,31  Solvation of cations 
certainly influences the interaction.  Cations that are well solvated face a larger 
!! 10 
desolvation cost to participate in cation-π interactions.  This can be observed in aqueous 
systems where the interaction of benzene with K+ is greater than with Na+.30 
Within proteins, positively charged lysine and arginine residues interact with 
aromatic phenylalanine, tyrosine, and tryptophan.  These cations are often seen with the 
alkyl chains packed against the aromatic face, for example the methyl groups of of 
methylated lysine or the ε-methylene of unmethylated lysine, as this is where the partial 
positive charge actually lies (Figure 1.6).  Analysis of the PDB estimates that there is one 
cation-π interaction for every 77 amino acid residues, and about 26% of all tryptophan 
residues are involved in cation-π interactions.23,32  In intermolecular protein-protein 
interactions, cation-π interactions were present in about half of all complexes and one 
third of all homodimers.32   
 
Figure 1.6. Location of partial charges on a quaternary ammonium  
 
 
 
 
 
 
 
 
 
H3C N CH3
CH3H3C
+0.34-0.36
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1.4.2 Substituent Effects on Cation-π Interactions 
 
 While the net interaction energy is dependent on several forces, including van der 
Waals and the hydrophobic effect, the variance in the strength of cation-π interactions 
result from differences in electrostatic interactions.33   With aromatic rings, this can be 
estimated quite well using electrostatic potential maps (Figure 1.7).34  Electron 
withdrawing substituents reduce the negative electrostatic potential of the ring.  This 
correlates nicely with the reduced binding energy measured for Na+ in the gas phase.  
These energies also roughly correlate with σmeta values, as resonance effects do not play a 
role in cation-π binding energies.31,33   
Recent computation studies have provided an alternative model for substituent 
effects on cation-π interactions.25,35–37  The results suggest that differences in energies are 
 
Figure 1.7. Electrostatic potential maps of a cation-π interaction between 
benzene and ammonium cation (top) and toluene with increasing amounts (1-4) 
of fluorine substitution.23 Adapted from Dougherty, D.A. Acc. Chem. Res. 2013, 
46, 4, 885-893. Copyright 2013 American Chemical Society 
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primarily the result of through space interactions with the dipole between the carbon and 
the substituent, rather than a change in the electron density of the π-cloud over the center 
of the ring.35,36   
1.4.3 Studying Cation-π Interactions in Biological Systems 
There have been many model systems developed to study and quantify cation-π 
interactions, estimating them to be worth about 1-2 kcal/mol/ring.23  Among the first 
small molecule model systems that pointed to the potential of cation-π interactions were 
cyclophane receptors.38,39 These receptors were known to bind small aromatic 
compounds, but were also found to bind quaternary ammonium ions in aqueous 
systems.40   Since then, a variety of synthetic receptors have been developed to bind 
quaternary ammonium ions, and more specifically, cationic methylated amino acid 
residues and peptides.41–54 
 Peptide models have incorporated cation-π interactions to increase structural 
stability as well as to quantify the strength of the interaction.55  For example, 
incorporation of an Arg/Lys and Trp pair at the i, i+4 positions of an α-helix stabilized 
the structure by 0.4 kcal/mole, while the interaction of Phe with either Lys or Arg was 
weaker, but still stabilizing by about 0.1 to 0.2 kcal/mol.56–58 
β-hairpin peptides containing cross-strand cation-π interactions have provided 
further insight into magnitude of these interactions.59–61   The cross-strand interaction 
between cationic lysine and arginine and aromatic amino acids tryptophan and 
phenylalanine stabilized the hairpins by about 0.2 to 0.5 kcal/mol.61   
Studies with these hairpins were also done with methylated lysine and arginine 
residues.  Increasing amounts of methylation on these residues increased the magnitude 
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of this interaction in aqueous solutions.62–64   Unmethylated lysine is protonated and 
therefore positively charged at neutral pH, and so it is still capable of participating in 
cation-π interactions.  However, increased amounts of methylation increases the 
interaction, presumably due to decreasing the desolvation cost of the cation and increased 
surface area for van der Waals interactions.   
1.4.4 Using Neutral Analogs to Probe Cation-π Interactions 
One approach that has been frequently used to study cation-π between aromatic 
amino acid residues and trimethyllysine has been the replacement of the quaternary 
ammonium of the trimethyllysine with a neutral isostere, a tert-butyl group. The analog 
has similar size (and van der Waals interactions) and increased hydrophobicity but lacks 
the positive charge.  By replacing trimethyllysine with these neutral analogs in systems, 
the role of the cation can be further investigated.  This substitution has been used in 
various systems including host-guest, protein-peptide, protein-inhibitor, and protein-
nucleotide to evaluate the contribution of electrostatics to the interaction.22,40,65,66  
Interestingly, the results of these studies frequently measure very similar values, usually 
around 2.5 kcal/mol for the contribution of the cation to binding (Figure 1.8).  
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One of the simplest examples using a neutral analog to demonstrate importance of 
the cation is a small molecule that can fold and unfold.67   An indole ring connected with 
a linker to a quaternary ammonium, can be compared to the molecule with a tert-butyl 
group in place of the ammonium (Figure 1.9).  X-ray analysis demonstrated that the 
compound containing the ammonium was folded in a way that placed the ammonium 
near the indole ring.  The neutral analog, however, was unfolded.  These differences 
demonstrate the preference for the cation to interact with the indole ring.  
Figure 1.8.  Neutral isosteres used to determine electrostatic contributions of cation-p 
interactions.  Interactions between reader proteins and trimethylysine (left), 
macrocycle and guest (center), and inhibitor of factor XA (right), are examples of 
systems studied with observed ΔΔG values around 2.5 kcal/mol. Adapted with 
permission from J. Am. Chem. Soc. 1988, 110 (6), 1983–1985, Copyright 1988 
American Chemical Society; Proc. Natl. Acad. Sci. U. S. A. 2007, 104 (27), 11184–
11188, Copyright 2007 National Academy of Sciences, USA, Copyright 1988 
American Chemical Society; Angew. Chemie - Int. Ed. 2009, 48 (4), 811–814, 
Copyright 2009, John Wiley and Sons. 
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Factor XA is a serine protease involved in blood coagulation that has been 
similarly probed.  It has three aromatic residues, Trp, Tyr, and Phe, that are proposed to 
be involved in a cation-π interaction with an ammonium group of an inhibitor. 68  The 
inhibitor was synthesized with a neutral tert-butyl group in place of the ammonium group 
and the binding affinities were compared.  Using this method, the electrostatics 
contributed 2.8 kcal/mol to the binding.69 
One of the most well studied examples of cation-π interactions between proteins 
and nucleic acids has been with 7-methyl guanine. This methylation is an important part 
of RNA processing, and forms the 5’ cap.  Various proteins with different functions 
recognize the 5’ cap.70  One such protein, eukaryotic initiation factor 4E, binds to the 5’ 
cap and triggers translation.  Crystal structure analysis shows the methylated guanine 
base sandwiched between two tryptophan residues.70–72  The positive charge of the 7-
methyl G is thought to provide increased stability over π-π stacking interactions.  
Computation studies were done with the neutral analog 7-methyl D, which is capable of 
the stacking interaction but not the cation-π interaction (Figure 1.10).  The binding 
N
H
O
O
N
N
H
O
O
Figure 1.9.  Indole linked to cationic ammonium group adopted a folded 
comformation, while the neutral analog remained unfolded.76 
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affinity was calculated to be reduced by 2.8 kcal/mol.73
 
1.5 Reader Proteins and Cation-π Interactions 
As many reader proteins are thought to participate in cation-π interactions in the 
recognition of post-translational modifications, these methods can also be used to begin 
to probe and understand the mechanism of binding.  Computation and experimental 
studies were performed with reader proteins binding to histone peptides containing either 
trimethyllysine or the neutral, tert-butyl containing analog.74  Most of the reader proteins 
showed significant reduction in binding affinities with the neutral analog, often on the 
order of 2 kcal/mol, similar in magnitude to that observed in other systems.  
1.5.1 Heterochromatin Protein 1 
The first reader protein to be crystalized was the chromodomain of 
heterochromatin protein 1 (HP1) from Drosophila melanogaster. 75   This protein binds to 
di- and trimethyllyine 9 on histone 3 (H3K9Me3).  This binding is associated with 
heterochromatin formation and epigenetic silencing.  
Figure 1.10. Methylated bases for 7-methyl G (m7G) and neutral analog 7-
methyl D (m7D). 
HN
N N
N
H2N R
O
HN
N NH2N R
O
m7G m7D
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Y48 
Y24 W45 
Figure 1.11. Crystal structure of HP1 (green) bound to H3K9Me3 (cyan) with 
binding pocket highlighted in purple (left), and zoom in of binding pocket 
with aromatic residues labeled (right). PDB: 1KNE75 
Figure 1.12. Three stranded β-sheet formed between the H3 tail 
(blue) and HP1 (green). PDB: 1KNE75 
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It has been shown that the chomodomain alone of HP1 is sufficient for the 
binding interaction with H3K9Me3.  The chromodomain was crystalized with H3 
peptides (residues 1-15: ARTKQTARK(MeX)STGGKA) containing both di- (KMe2) and 
trimethyllysine (KMe3) at position 9. The crystal structure revealed a binding pocket 
consisting of three aromatic residues. Two tyrosine residues and a tryptophan residue 
surround the cationic ammonium (Figure 1.11), while a glutamic acid forms a water 
mediated salt bridge with KMe2. Residues 5-8 (QTAR) of the H3 peptide form a three 
standed β-sheet with the chromodomain (Figure 1.12), and serine 10 forms a hydrogen 
bond.  Binding affinities were measured by isothermal titration calorimetry (ITC).  The 
dissociation constant (Kd) for HP1 with H3 peptide with KMe3 was 2.5 µM, while the Kd 
with KMe2 was around 7 µM.  Mutation of any of the aromatic residues in the binding 
pocket to alanine drastically reduced binding.75  
Further evidence for cation-π interactions comes from previous work done in the 
Waters’ lab (Figure 1.8, left panel).22  By using the neutral analog approach, the neutral 
residue was both incorporated into a β-hairpin, as well as an H3 peptide.  The neutral 
analog destabilized the hairpin folding compared to trimethyllysine, and, when 
incorporrated in the H3 peptide, exhibited reduced binding affinity with HP1 on the order 
of 2 kcal/mol.  This was the initial evidence for the critical role of the cation in this 
binding interaction. 
 
 
 
 
!! 19 
REFERENCES 
(1)  Bianconi, E.; Piovesan, A.; Facchin, F.; Beraudi, A.; Casadei, R.; Frabetti, F.; 
Vitale, L.; Pelleri, M. C.; Tassani, S.; Piva, F.; Perez-Amodio, S.; Strippoli, P.; 
Canaider, S. Ann Hum Biol 2013, 40 (6), 301–4460. 
 
(2)  Esteller, M. N. Engl. J. Med. 2008, 358, 1148–1159. 
 
(3)  Egger, G.; Liang, G.; Aparicio, A.; Jones, P. a. Nature 2004, 429 (6990), 457–463. 
 
(4)  Liu, Y.; Liu, K.; Qin, S.; Xu, C.; Min, J. Pharmacol. Ther. 2014, 143 (3), 275–
294. 
 
(5)  Jenuwein, T.; Allis, C. D. Science (80-. ). 2001, 293 (5532), 1074–1080. 
 
(6)  McGinty, R. K.; Tan, S. Chem. Rev. 2015, 115 (6), 2255–2273. 
 
(7)  Bannister, A. J.; Kouzarides, T. Cell Res. 2011, 21 (3), 381–395. 
 
(8)  Fischle, W.; Wang, Y.; Allis, C. D. Curr. Opin. Cell Biol. 2003, 15 (2), 172–183. 
 
(9)  Lachner, M.; O’Sullivan, R. J.; Jenuwein, T. J. Cell Sci. 2003, 116 (Pt 11), 2117–
2124. 
 
(10)  Greer, E. L.; Shi, Y. Nat. Rev. Genet. 2012, 13 (5), 343–357. 
 
(11)  Rea, S.; Eisenhaber, F.; O’Carroll, D.; Strahl, B. D.; Sun, Z. W.; Schmid, M.; 
Opravil, S.; Mechtler, K.; Ponting, C. P.; Allis, C. D.; Jenuwein, T. Nature 2000, 
406 (6796), 593–599. 
 
(12)  Dillon, S. C.; Zhang, X.; Trievel, R. C.; Cheng, X. Genome Biol. 2005, 6 (8), 227. 
 
(13)  Tamaru, H.; Zhang, X.; McMillen, D.; Singh, P. B.; Nakayama, J.; Grewal, S. I.; 
Allis, C. D.; Cheng, X.; Selker, E. U. Nat. Genet. 2003, 34 (may), 75–79. 
 
(14)  Zhang, X.; Yang, Z.; Khan, S. I.; Horton, J. R.; Tamaru, H.; Selker, E. U.; Cheng, 
X. Mol. Cell 2003, 12 (1), 177–185. 
 
(15)  Xiao, B.; Jing, C.; Wilson, J. R.; Walker, P. A.; Vasisht, N.; Kelly, G.; Howell, S.; 
Taylor, I. A.; Blackburn, G. M.; Gamblin, S. J. Nature 2003, 421, 652–656. 
 
(16)  Cheng, X.; Collins, R. E.; Zhang, X. Annu. Rev. Biophys. Biomol. Struct. 2005, 34, 
267–294. 
 
(17)  Collins, R. E.; Tachibana, M.; Tamaru, H.; Smith, K. M.; Jia, D.; Zhang, X.; 
Selker, E. U.; Shinkai, Y.; Cheng, X. J. Biol. Chem. 2005, 280 (7), 5563–5570. 
!! 20 
 
(18)  Shi, Y.; Lan, F.; Matson, C.; Mulligan, P.; Whetstine, J. R.; Cole, P. A.; Casero, R. 
A.; Shi, Y. Cell 2004, 119 (7), 941–953. 
 
(19)  Tsukada, Y.; Fang, J.; Erdjument-Bromage, H.; Warren, M. E.; Borchers, C. H.; 
Tempst, P.; Zhang, Y. Nature 2006, 439 (February), 811–816. 
 
(20)  Taverna, S. D.; Li, H.; Ruthenburg, A. J.; Allis, C. D.; Patel, D. J. Nat. Struct. Mol. 
Biol. 2007, 14 (11), 1025–1040. 
 
(21)  Botuyan, M. V.; Lee, J.; Ward, I. M.; Kim, J. E.; Thompson, J. R.; Chen, J.; Mer, 
G. Cell 2006, 127 (7), 1361–1373. 
 
(22)  Hughes, R. M.; Wiggins, K. R.; Khorasanizadeh, S.; Waters, M. L. Proc. Natl. 
Acad. Sci. U. S. A. 2007, 104 (27), 11184–11188. 
 
(23)  Dougherty, D. A. Acc. Chem. Res. 2013, 46 (4), 885–893. 
 
(24)  Mahadevi, A. S.; Sastry, G. N. Chem. Rev. 2012, 113 (3), 2100–2138. 
 
(25)  Wheeler, S. E.; Bloom, J. W. G. J. Phys. Chem. A 2014, 118 (32), 6133–6147. 
 
(26)  Sunner, J.; Nishizawa, K.; Kebarle, P. J. Phys. Chem. 1981, 85 (13), 1814–1820. 
 
(27)  Meot-Ner, M.; Deakyne, C. a. J. Am. Chem. Soc. 1985, 107 (2), 474–479. 
 
(28)  Taft, R. W.; Anvia, F.; Gal, J.-F.; Walsh, S.; Capon, M.; Holmes, M. C.; Hosn, K.; 
Oloumi, G.; Vasanwala, R.; Yazdani, S. Pure Appl. Chem. 1990, 62 (1), 17–23. 
 
(29)  Guo, B. C.; Purnell, J. W.; Castleman, A. W. Chem. Phys. Lett. 1990, 168 (2), 
155–160. 
 
(30)  Kumpf, R. A.; Dougherty, D. A. Science (80-. ). 1993, 261 (5129), 1708–1710. 
 
(31)  Ma, J. C.; Dougherty, D. A. Chem. Rev. 1997, 97 (5), 1303–1324. 
 
(32)  Gallivan, J. P.; Dougherty, D. a. Proc. Natl. Acad. Sci. U. S. A. 1999, 96 (17), 
9459–9464. 
 
(33)  Mecozzi, S.; West, A. P.; Dougherty, D. A. J. Am. Chem. Soc. 1996, 118 (9), 
2307–2308. 
 
(34)  Mecozzi, S.; West, A. P.; Dougherty, D. A. Proc. Natl. Acad. Sci. U. S. A. 1996, 
93 (20), 10566–10571. 
 
(35)  Sherrill, C. D. Acc. Chem. Res. 2013, 46 (4), 1020–1028. 
!! 21 
 
(36)  Wheeler, S. E.; Houk, K. N. J. Am. Chem. Soc. 2009, 131 (9), 3126–3127. 
 
(37)  Wheeler, S. E. Acc. Chem. Res. 2012, 46 (4), 1029–1038. 
 
(38)  Shepodd, T. J.; Petti, M. A.; Dougherty, D. A. J. Am. Chem. Soc. 1986, 108 (19), 
6085–6087. 
 
(39)  Diederich, F.; Dick, K. J. Am. Chem. Soc. 1984, 106 (26), 8024–8036. 
 
(40)  Petti, M. A.; Shepodd, T. J.; Barrans, R. E. J.; Dougherty, D. A. J. Am. Chem. Soc. 
1988, 110 (1), 6825–6840. 
 
(41)  Murayama, K.; Aoki, K. Chem. Commun. 1997, No. 1, 119–120. 
 
(42)  Murayama, K.; Aoki, K. Chem. Commun. 1998, No. 12, 607–608. 
 
(43)  Shivanyuk, A.; Rebek, J. Proc. Natl. Acad. Sci. 2001, 98 (14), 7662–7665. 
 
(44)  Koh, K. N.; Araki, K.; Ikeda,  a; Otsuka, H.; Shinkai, S. J. Am. Chem. Soc. 1996, 
118 (4), 755–758. 
 
(45)  Lhoták, P.; Shinkai, S. J. Phys. Org. Chem. 1997, 10 (5), 273–285. 
 
(46)  Daze, K. D.; Pinter, T.; Beshara, C. S.; Ibraheem, A.; Minaker, S. A.; Ma, M. C. 
F.; Courtemanche, R. J. M.; Campbell, R. E.; Hof, F. Chem. Sci. 2012, 3 (9), 2695. 
 
(47)  Hof, F.; Trembleau, L.; Ullrich, E. C.; Rebek, J. Angew. Chemie - Int. Ed. 2003, 42 
(27), 3150–3153. 
 
(48)  Gamal-Eldin, M. a; Macartney, D. H. Org. Biomol. Chem. 2013, 11 (3), 488–495. 
 
(49)  Corbett, P. T.; Leclaire, J.; Vial, L.; West, K. R.; Wietor, J.-L.; Sanders, J. K. M.; 
Otto, S. Chem. Rev. 2006, 106 (9), 3652–3711. 
 
(50)  Gagné, M. R.; Ghosh, S.; Ingerman, L. a.; Frye, A. G.; Lee, S. J.; Waters, M. L. 
Org. Lett. 2010, 12 (5), 1860–1863. 
 
(51)  Pinkin, N. K.; Waters, M. L. Org. Biomol. Chem. 2014, 7059–7067. 
 
(52)  E. Beaver, J.; C. Peacor, B.; V. Bain, J.; James, L. I.; L. Waters, M. Org. Biomol. 
Chem. 2015, 13 (11), 3220–3226. 
 
(53)  James, L. I.; Beaver, J. E.; Rice, N. W.; Waters, M. L. J. Am. Chem. Soc. 2013, 
135 (17), 6450–6455. 
 
!! 22 
(54)  Beaver, J. E.; Waters, M. L. ACS Chem. Biol. 2016, 11 (3), 643–653. 
 
(55)  Waters, M. L. Biopolymers 2004, 76 (5), 435–445. 
 
(56)  Shi, Z.; Olson, C. A.; Kallenbach, N. R. J. Am. Chem. Soc. 2002, 124 (13), 3284–
3291. 
 
(57)  Andrew, C. D.; Bhattacharjee, S.; Kokkoni, N.; Hirst, J. D.; Jones, G. R.; Doig, A. 
J. J. Am. Chem. Soc. 2002, 124 (43), 12706–12714. 
 
(58)  Tsou, L. K.; Tatko, C. D.; Waters, M. L. J. Am. Chem. Soc. 2002, 124 (50), 
14917–14921. 
 
(59)  Hughes, R. M.; Waters, M. L. J. Am. Chem. Soc. 2006, 128 (41), 13586–13591. 
 
(60)  Andersen, N. H.; Olsen, K. A.; Fesinmeyer, R. M.; Tan, X.; Hudson, F. M.; 
Eidenschink, L. A.; Farazi, S. R. J. Am. Chem. Soc. 2006, 128 (18), 6101–6110. 
 
(61)  Tatko, C. D.; Waters, M. L. Protein Sci. 2003, 12 (11), 2443–2452. 
 
(62)  Hughes, R. M.; Waters, M. L. J. Am. Chem. Soc. 2005, 127 (18), 6518–6519. 
 
(63)  Hughes, R. M.; Waters, M. L. J. Am. Chem. Soc. 2006, 128 (39), 12735–12742. 
 
(64)  Hughes, R. M.; Benshoff, M. L.; Waters, M. L. Chem. - A Eur. J. 2007, 13 (20), 
5753–5764. 
 
(65)  Shepodd, T. J.; Petti, M. A.; Dougherty, D. A. J. Am. Chem. Soc. 1988, 110 (6), 
1983–1985. 
 
(66)  Salonen, L. M.; Bucher, C.; Banner, D. W.; Haap, W.; Mary, J. L.; Benz, J.; 
Kuster, O.; Seiler, P.; Schweizer, W. B.; Diederich, F. Angew. Chemie - Int. Ed. 
2009, 48 (4), 811–814. 
 
(67)  Aoki, K.; Murayama, K.; Nishiyama, H. J. Chem. Soc. Chem. Commun. 1995, 764 
(21), 2221. 
 
(68)  Maignan, S.; Guilloteau, J. P.; Choi-Sledeski, Y. M.; Becker, M. R.; Ewing, W. R.; 
Pauls, H. W.; Spada, A. P.; Mikol, V. J. Med. Chem. 2003, 46 (5), 685–690. 
 
(69)  Schärer, K.; Morgenthaler, M.; Paulini, R.; Obst-Sander, U.; Banner, D. W.; 
Schlatter, D.; Benz, J.; Stihle, M.; Diederich, F. Angew. Chemie - Int. Ed. 2005, 44 
(28), 4400–4404. 
 
(70)  Marcotrigiano, J.; Gingras,  a C.; Sonenberg, N.; Burley, S. K. Nucleic Acids 
Symp. Ser. 1997, 89 (36), 8–11. 
!! 23 
 
(71)  Brown, C. J.; McNae, I.; Fischer, P. M.; Walkinshaw, M. D. J. Mol. Biol. 2007, 
372 (1), 7–15. 
 
(72)  Tomoo, K.; Shen, X.; Okabe, K.; Nozoe, Y.; Fukuhara, S.; Morino, S.; Ishida, T.; 
Taniguchi, T.; Hasegawa, H.; Terashima, A.; Sasaki, M.; Katsuya, Y.; Kitamura, 
K.; Miyoshi, H.; Ishikawa, M.; Miura, K. Biochem. J. 2002, 362, 539–544. 
 
(73)  Guimarães, C. R. W.; Kopecky, D. J.; Mihalic, J.; Shen, S.; Jeffries, S.; Thibault, 
S. T.; Chen, X.; Walker, N.; Cardozo, M. J. Am. Chem. Soc. 2009, 131 (50), 
18139–18146. 
 
(74)  Kamps, J. J. a. G.; Huang, J.; Poater, J.; Xu, C.; Pieters, B. J. G. E.; Dong, A.; Min, 
J.; Sherman, W.; Beuming, T.; Matthias Bickelhaupt, F.; Li, H.; Mecinović, J. Nat. 
Commun. 2015, 6, 8911. 
 
(75)  Jacobs, S. A.; Khorasanizadeh, S. Science (80-. ). 2002, 295 (5562), 2080–2083. 
 
(76)  Aoki, K.; Murayama, K.; Nishiyama, H. J. Chem. Soc. Chem. Commun. 1995, 764 
(21), 2221. 
 
 
 
! 24 
!! !
CHAPTER 2: PROBING THE CONTRIBUTION OF TYROSINE RESIDUES TO 
CATION-Π INTERACTIONS IN HP1 
 
2.1 Background !
 Heterochromatin Protein 1 (HP1) has been extensively studied, including mutation 
studies and crystal structure analysis, making it a good model system to initiate studies designed 
to tune the electronics of cation-π interactions.1–3 There is strong evidence for cation-π 
interactions already, however the contributions of the individual tyrosine residues is unknown.4,5  
Detailed mechanistic information about the contribution of tyrosine provides information useful 
about the recognition of their native substrates, providing more guidelines developing drugs that 
bind to these types of reader proteins with similar affinity and specificity.  Tuning the electronics 
of aromatic residues by incorporating electron withdrawing groups on the aromatic ring is an 
approach that has been used in a variety of systems to identify important cation-π interactions, 
and can be applied to the tyrosine residues of HP1.6 
2.1.1 Tuning Cation-π Interactions of Ligand Gated Ion Channels 
 Some of the most extensively studied systems are the nicotinic acetylcholine receptors 
(nAChR). 7–12 These proteins belong to a superfamily of proteins that include receptors for 
serotonin, γ-aminobutyric acid, and glycine.9 The nAChR is a ligand gated ion channel that binds 
to the quaternary ammonium of acetylcholine. This channel also binds to nicotine, which also 
contains an ammonium ion, and the interaction is the chemical basis for nicotine addiction.9  
While there are no crystal structures available of the membrane bound protein, it is thought to 
adopt a structure similar to other AChE binding proteins (Fig. 2.1).8,12   
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Figure 2.1.  Aromatic residues of a binding region of an ACh binding protein. PDB:1I9B.12 
 The binding site was found to contain a large number of aromatic residues, suggesting 
that cation-π interactions may play an important role in the recognition of the ammonium 
substrates.13  In order to test for the presence of important cation-π interactions, mutations were 
made to the aromatic residues that have potential for participating in this binding interaction.  If 
the residue is participating in a cation-π interaction, it should exhibit similar substituent effects to 
those calculated in the gas phase.  Incorporation of electron withdrawing groups weakens the 
ability of the residue to participate in cation-π interactions, and should therefore reduce the 
overall binding affinity if a cation-π interaction is present.  A linear free energy relationship will 
be observed if there is a liner correlation between log of the Ka values (or ΔG) plotted against the 
calculated gas phase ΔG values.  Linear correlation demonstrates a linear free energy 
relationship and suggests the same mechanism of binding. This is a common approach for 
probing mechanism of reactions and interactions that can be tuned with electronics. The simplest 
way to achieve this is by the incorporation of increasing numbers of fluorine atoms on the ring 
(Figure 2.2).   
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Fluorine is often the optimum choice as it is the most electronegative atom, and, as a single, 
small atom, it typically has minimal steric effects.  
 
 
 As the nAChR system contains a membrane bound protein, it is not possible to measure 
direct binding affinities.  Instead, EC50 values were measured under the assumption that 
decreased binding of the ACh leads to decreased activity.  Using this method the potential 
cation-π interactions were probed at all aromatic residues in the binding region.  Interestingly, no 
Tyrosine residues exhibited a correlation in activity upon mutation with electron poor aromatic 
residues, and only one tryptophan residue demonstrated a linear free energy relationship.8,9 This 
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Figure 2.2. Electrostatic potential maps of tryptophan with 0, 2, and 4 
fluorine atoms (top), phenylalanine (bottom left), tyrosine (bottom center), 
and tetrafluorotyrosine (bottom right). Electrostatic potential maps were 
generated with MacSpartan: HF/6-31G*; isodensity value = 0.02; range = -
50 (red, electron rich) to 50 kcal/mol (blue, electron poor). 
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interaction is also seen in the recognition of nicotine by these receptors in the brain.8  However, 
in the muscle-type acetylcholine receptors, this cation-π interaction with tryptophan is absent, 
and thus, the binding energy for nicotine is greatly reduced.  Without this weakening of the 
interaction, nicotine would stimulate the muscle receptors in addition to the brain and have 
detrimental consequences.  This study provided detailed mechanistic insight into the mechanism 
of nicotine addiction and the basis for selectivity of this interaction. 
 Several other systems that contain a cation-π interaction have been studied using this 
approach. Other ligand gated-ion channels have also been shown to participate in important 
cation-π interactions,14 as well as GABA,15 glycine,16 and 5-HT317 receptors, and have aided in 
the development of agonists and further biochemical studies of these receptors.18–20 
2.1.2 Tuning Cation-π Interactions of Enzymes 
 Terpene synthase enzymes have commonly been thought to rely on cation-π interactions 
to stabilize their carbocation intermediates.  Unnatural amino acid mutagenesis studies replacing 
aromatic residues with either fluorinated residues21,22 or phenyl alanine derivatives containing 
para-substituted electron withdrawing groups23 led to decreased activity of the enzymes and 
reduced product formation for several aromatic residues (Figure 2.3). However, like the ligand 
gated ion channels, it is unclear whether structural changes are impacting binding of the 
substrates. 
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Figure 2.3. Linear free energy relationship between activity of Aristocholene Synthase upon 
mutation and calculated cation-π binding energies. Reproduced with permission from J. Am. 
Chem. Soc. 2011, 133 (35), 13906–13909. Copyright 2011, American Chemical Society. 
 
 This approach can help develop a detailed understanding for the mechanism of binding 
selectivity reader proteins have for their substrates.  As there are three residues in the aromatic 
pocket of HP1, it is possible that not all of them contribute to the interaction, or contribute to the 
interaction by different magnitudes.  Additionally, as the nAChR system did not have tyrosine 
residues that exhibited a linear free energy relationship, it is unknown whether the same will be 
seen with HP1.  Initial mutagenesis studies comparing the two tyrosine residues provide a deeper 
understanding of the role these residues play in the binding of trimethyllysine. 
2.2 System Design 
2.2.1 Unnatural Amino Acid Mutagenesis  
 Because the measurement of binding interactions requires over-expression and isolation 
of the protein of interest, unlike the measurements done on Dougherty’s ACh receptors, similar 
methods for incorportation of unnatural amino acid mutagenesis cannot be used, as only single 
cells are amenable to this approach because chemical synthesis is required to link tRNA 
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W334p-(CF3)F, and W334p-(NO2)F were similar to that ob-
served for PR-AS-W334H, a mutant in which cation!π interac-
tions are precluded due to protonation of the imidazole ring.
Hence, as suggested by the results in Table 1, the relative
amounts of 2 produced by the mutants seem unambiguously
associated with the progressively decreased π-electron density
rather than with the inherent bulk of the PR-AS-W334XparaF (or
PR-AS-W334X) enzymes. Had steric bulk of amino acid 334
been the driving force for progression through the catalytic cycle,
substituents such as p-(NO2) and p-(CF3) might have been
expected to increase the mount of aristolochene. The fact that
the introduction of the substituents led to a decrease in aristo-
lochene production indicates the importance of electronic eﬀects
on stabilization of the transition state leading to 3. Indeed,
substitution of tryptophan by phenylalanine (PR-AS-W334F,
Table 1) or by a bicyclic aromatic amino acid (PR-AS-W334-
naphthyl, Table 2), two aromatic residues of similar cation!π
binding energy,25 led to the production of comparable amounts
of aristolochene (82 and 78%). Likewise, the reduction in
aristolochene produced by PR-AS-W334naphthyl relative to
the wild-type enzyme correlates with the reduction in the
cation!π binding energy of the naphthyl group relative to the
indole ring.25 The groups of Dougherty25 and Houk26 have
calculated binding energies of sodium cation to substituted
benzene rings. A plot of the percentage of aristolochene pro-
duced by PR-AS and its mutants against their Na+!π binding
energies showed a good correlation (Figure 2), indicating a
strong contribution from the indole ring of Trp 334 to the
energetically demanding conversion of 2 to 3 in PR-AS catalysis.
Similar to Trp 334, it is likely that the PR-AS active-site
residues Tyr 92, Phe 112, and Phe 178 (Figure 1) are also
involved in the stabilization of carbocationic intermediates along
the reaction pathway outlined in Scheme 1.11 In addition,
sequence alignments of plant terpene synthases, together with
the high structural similarities of all class I terpenoid synthase
folds, suggest that aromatic quadrupoles are generally important
for the stabilization of cationic transition states and intermediates
in terpene biosynthesis. For instance, Trp 273 of TEAS,30 which
shows no homology to PR-AS, is in a position similar to that of
Trp 334 in PR-AS; hence, 3 in TEAS is most likely stabilized
through interaction with the π-system of Trp 273. Cation!π
interactions have recently been shown to be involved in the
cationic polycyclization cascade catalyzed by a squalene!hopene
cyclase.31
In summary, the results reported here provide strong support
for the signiﬁcance of cation!π interactions for the energetically
demanding stabilization of transition states and reaction inter-
mediates in sesquiterpene synthase chemistry. Active sites rich in
aromatic residues provide the ideal environment for the tight and
selective binding of carbocations in the non-polar environment
required for the synthesis of hydrocarbon products.
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molecules to the desired unnatural amino acid.  For larger scale mutagenesis, the cells machinery 
is used to incorporate the unnatural amino acid.24–26  To accomplish this, orthoganol tRNA tRNA 
synthetase pair is used to load an unnatural amino acid onto a tRNA in cells.  To ensure site-
specific incorporation, and Amber (TAG) stop codon is used, as it is the least common stop 
codon in the bacterial genome.25 Synthetases capable of loading unnatural amino acids 
selectively onto a tRNA that decodes this amber codon have been developed for a variety of 
amino acids.  By incorporating this amber codon at the position of mutation, these orthogonal 
pairs will incorporate the unnatural amino acid at that position instead of stopping, provided the 
amino acid is given to the cells, allowing for selective and site-specific mutation to an unnatural 
amino acid.   
2.2.2 HP1 Mutants 
These methods currently do not allow for the efficient and incorportation of fluorinated 
phenylalanine, as it is too similar to natural phenylalanine and native synthetases will recognize 
it, leading to global incorporation at any phenylalanine site.  Site specific incorporation studies 
for fluorinated phenylalanine incorporation are in their initial stages.27  Instead, the use of other 
para-substituted phenyalanines with common electron withdrawing groups were used to probe 
the cation-π interactions at the tyrosine positions (Figure 2.4). 
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Figure 2.4. Electrostatic potential maps of some of the mutant amino acid residues incorporated 
into the binding pocket of HP1 by unnatural amino acid mutagenesis. Electrostatic potential 
maps were generated with MacSpartan: HF/6-31G*; isodensity value = 0.02; range = -50 (red, 
electron rich) to 50 kcal/mol (blue, electron poor). 
 
Various mutations were incorporated into the binding pocket of HP1 in both of the 
tyrosine residue positions (Y24 and Y48) of the HP1 binding pocket by Stef Baril in the Brustad 
lab at UNC.  The mutations and the calculated cation-π binding energies of the corresponding 
substituted benzene are summarized in Table 2.1. 
Table 2.1. Mutations of HP1 chromodomain and the calculated cation-π binding energies of 
the substituent on benzene 
Entry Protein 
Cation-π 
Energy28 
(kcal/mol) 
Expected Mass Observed Massa 
1 Wild Type 15.2 8569.30 8569.59 
2 Y24pMeF 16.4 8567.46 8567.11 
3 Y24F 15.9 8553.31 8553.60 
4 Y24pCF3F 7.2 8621.42 8622.13 
5 Y24pCNF 3.4 8578.43 8578.98 
6 Y24pNO2F 1.6 8598.39 8598.80 
7 Y48pMeF 16.4 8567.46 8568.10 
8 Y48F 15.9 8553.31 8553.85 
9 Y48pCF3F 7.2 8621.42 8622.09 
10 Y48pCNF 3.4 8578.43 8579.01 
11 Y48pNO2F 1.6 8598.39 8598.71 
aExpressed by Stef Baril, Brustad lab and measured by LC-MS 
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•  Systematically vary the aromatic residues in the binding pocket 
•  Measure binding affinity, selectivity, and structure to probe mechanism 
•  Recognition of trimethyllysine is in an important protein-protein interaction in 
gene expression 
•  The dysregulation of these interactions is found in many disease states, making 
the readers of trimethyllysine popular drug targets 
•  Reader proteins often contain an aromatic cage that interacts with methylated 
lysine via cation-π interactions1 
•  Heterochromatin protein 1 (HP1), contains two tyrosine residues and one 
tryptophan residue in its binding pocket, and recognizes di- and trimethyllysine 
•  Mutations of each aromatic residue to alanine diminishes binding to 
trimethyllysine2 
 
 
 
 
 
 
 
 
 
Remaining Questions: 
•  Do all aromatic residues contribute equally? 
•  Does hydrogen bonding impact the contribution of cation-π interactions? 
•  Does the mechanism of binding differ between reader proteins? 
•  Do inhibitors bind via the same mechanism? 
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W45 
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 Crystal structure of HP1 bound to trimethyllysine (left) and aromatic cage (right) 
Overall scheme of protein SAR studies 
•  Altering the electronics of an aromatic residue changes its ability to participate in 
cation-π interactions.   
 
•  Electron withdrawing groups on the aromatic rings reduces its ability to 
participate in a cation-π interactions 
•  Residues participating in a cation-π interaction with trimethyllysine will exhibit 
a correlation between ring electronics and binding affinity 
•  Fluorine is the ideal substituent for these studies due to its electron 
withdrawing ability and relatively small size 
•  Methods exist for incorporating many phenylalanine derivatives containing either 
electron withdrawing or electron donating groups 
•  Collaborators in the Brustad lab have expressed HP1 mutants containing methoxy, 
chloro, cyano, and nitro substituents on phenylalanine in place of tyrosine 
        Toluene                      p-cresol            p-chlorotoluene          p-cyanotoluene        p-nitrotoluene  
Red = electron-rich; blue = electron poor.  
Circular dich oism of expressed HP1 muta ts containing a  
p-chlorophenylalanine mutation at each tyrosine position demonstrates proper 
folding of each mutant. Plots of log Ka vs σmeta (top left); calculated cation-π strength (kcal/mol; top right); 
polarizability (bottom left); Log P (bottom right) 
•  Fluorinated analogs cannot be incorporated by traditional unnatural amino acid 
mutagenesis techniques. Synthetic methods needed to incorporate fluorinated 
tryptophan 
•  Acetyl capping after coupling steps eliminates deletion products from incomplete 
couplings 
•  Attaching a tag for affinity chromatography simplifies purification and isolation of 
only the full length protein 
•  Log Ka correlates with both σmeta values and calculated cation-π energies when 
tyrosine 24 is replaced with para-substituted phenylalanines  
 
•  Tyrosine 24 exhibits a tunable cation-π interaction with trimethyllysine 
•  Polarizability correlates inversely with log Ka, indicating van der Waals interactions 
are not driving binding 
•  Log P, a measure of hydrophobicity, shows no correlation with binding 
After Affinity Chromatography 
•  Unnatural amino acids incorporated into HP1 via unnatural amino acid mutagenesis 
•  Mutations do not prevent folding of protein 
•  Solid phase peptide synthesis techniques developed for synthesis of HP1 allow for 
incorporation of other unnatural amino acids 
•  Tyrosine 24 exhibited a tunable cation-π interaction with trimethyllysine 
 
•  Future work will include studying the other aromatic positions of HP1 
•  Method can be expanded to other reader proteins  
•  Binding mechanisms of natural substrates can be compared to those of developed 
inhibitors 
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2.3 Characterization of Structure 
2.3.1 Circular Dichroism 
 Circular dichroism is a technique often used to monitor protein structure.  Each type of 
secondary structure has a unique pattern of maxima and minima, and the CD spectra of HP1, as 
well as several mutants containing natural amino acid mutations have already been 
characterized.3  The spectra have local maxima around 233 nm that is generally attributed to 
exciton coupling arising from aromatic interactions.29,30  The minima at 209 nm and 222 nm are 
primarily reflective of alpha helical secondary structure.  
 
Figure 2.5. Circular dichroism of HP1 and all of the unnatural mutants used for probing cation-π 
interactions at tyrosine.  Experiments done in 10 mM sodium phosphate buffer, pH 7.4, 2 mM 
DTT at 20°C 
 
 
These CD structures of all the mutants demonstrate that the mutations did not significantly alter 
the folding of the chromodomain, and any observed effect we see on binding is not due to 
misfolded protein (Figure 2.5).  
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2.3.2 X-Ray Structures 
 Further evidence for this comes from x-ray analysis performed by Stef Baril in the 
Brustad lab.  Crystal structures were solved for mutants Y24F and Y24NO2 (Figure 2.6).   
 
Figure 2.6. A) Crystal structure of Y24pNO2F (cyan) and Y24F (magenta) overlayed with WT 
(green) indicating that binding pocket remains in tact with the mutated residue. B) overlay of 
Y24F and WT C) overlay of Y24pNO2F and WT D) overlay of Y24pNO2F and Y24F mutants. 
 
 The structures show the aromatic pocket remains in a similar position when either 
phenylalanine or the unnatural para-nitro amino acid is inserted in the Y24 position.  The para-
nitro substitution is both the largest mutation sterically, and the mutation that caused the largest 
disruption in binding, indicating that any of the effects observed in binding is not a result of any 
change in structure of the binding pocket.  The overlay of the mutants with the WT binding 
pocket indicates very little perturbation of structure. 
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2.4. Binding Affinities of HP1 Mutants 
2.4.1 Fluorescence Anisotropy 
 Initial binding measurements of HP1 and mutants were done by fluorescence anisotropy 
and based on previous work in the lab (Table 2.2).3  This method measures relies on changes of 
polarization of light observed upon binding.31  One binding partner is attached to a fluorophore, 
in this case the H3K9Me3 peptide.  When the peptide is tumbling in solution feely, upon 
excitation with plane polarized light, the tumbling will cause the light emitted back to become 
scrambled.  When HP1 is added to the solution, the binding interaction slows down this 
tumbling, and the light emitted back will retain some of the polarization.  The amount of 
polarization remaining can be measured for different concentrations of HP1 and a binding curve 
can be generated and analyzed by curve fitting software. Initial measurements of wild type HP1 
gave a Kd of 20 µM, comparable to those previously reported in the same conditions.3   
 
Table 2.2. Fluorescence polarization binding data for wild type HP1 and mutants 
Entry Protein σmeta Kd (µM) ΔG
 
(kcal/mol) 
1 Wild Type 0.12 203 -6.40.1 
2 Y24F 0 154 -6.60.1 
3 Y24pClF 0.37 245 -6.30.1 
4 Y24pCNF 0.56 437 -5.90.1 
 
2.4.1.1 Linear Free Energy Relationships 
 Initial mutation studies were done with mutating position 24 as the yields of the mutants 
were much higher than position 48 (Stef Baril, unpublished results).  Binding measurements of 
several mutant proteins followed the trend expected if the tyrosine residue was participating in a 
cation-π interaction.  To analyze the data, it can be plotted against values that represent the 
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relative electronics of the ring.  One such constant, σmeta is derived from the relative amounts of 
deprotonation of benzoic acid with various substituents in the meta position.  Electron 
withdrawing groups lead to a greater extent of deprotonation, and have a greater σmeta value.32  
Cation-π interactions exhibit a linear free energy relationship when various substituted aromatics 
are plotted against σmeta rather than the para position, indicating resonance effects do not 
contribute to the variation in strengths of cation-π interactions.  When the HP1 mutants are 
plotted against σmeta a clear linear free energy relationship was observed (Figure 2.7). 
  
Figure 2.7. Linear free energy relationship between binding data of position 24 mutants of HP1. 
Slope = -0.73; R2 = 0.90. 
 
 As subsequent binding experiments were performed using this method, batch to batch 
inconsistencies were observed.  While the linear relationship remained similar, the actual binding 
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affinities fluctuated greatly and experiments performed on the different days could not be 
compared to each other.   
 
Additionally, the same batch of protein gave relatively inconsistent data when several 
runs were done on the same day (Figure 2.8). 
 
Figure 2.8. Three runs performed on the same batch of protein on the same day.  The range of 
measured Kd values (shown in the table as m2) was 8 µM to 23 µM. 
 
The inconsistencies with this method were attributed to inaccurate protein concentrations of the 
stock solutions and error in dilutions. This led to the exploration of other methods that do not 
rely on accurate protein concentration for calculation of binding constants. 
2.4.2 Isothermal Titration Calorimetry  
Isothermal titration calorimetry (ITC) has previously been used to measure binding of 
HP1 to H3 peptides as well.2  ITC is performed by titration of the  peptide into a cell containing a 
solution of protein.  The instrument measures the heat released by with each injection.  
Consecutive injections are performed until the protein saturates.  The heat released can be plotted 
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relative to molar equivalents of titrant to give a binding isotherm, directly measuring Kd and ΔH, 
which can be used to calculate ΔS, independent of protein concentration.   Using this method, 
binding measurements to H3K9Me3 were performed. 
This time, batch to batch consistency was observed, and runs from different batches, and 
different days could be compared (Figure 2.9). Binding data from this method is summarized in 
Table 2.3. 
 
 
Figure 2.9. Two runs of WT HP1 with H3K9Me3 on two different days with two different 
batches of protein. 
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Table 2.3. Binding constants for HP1 mutants as measured by ITC 
Entry Protein Cation-π 
Energy28 
(kcal/mol)  
Kd (µM)a ΔGa 
(kcal/mol) 
C Valueb [M]:[L]d 
1 Wild Type 15.2 14±1 -6.58±0.07 17.9 1:20.0 
2 Y24pMeF 16.4 18±0.2 -6.44±0.1 13.5 1:12.3 
3 Y24F 15.9 19±0.2 -6.41±0.06 8.4 1:18.75 
4 Y24pClF N/A 22±0.4 -6.32±0.06 11.4 1:19.8 
5 Y24pCF3F 7.2 54±0.4 -5.79±0.07 4.6 1:20.0 
6 Y24pCNF 3.4 103±14 -5.42±0.1c 2.4 1:20.0 
7 Y24pNO2F 1.6 141±11 -5.23±0.16 1.4 1:25.6 
8 Y48pMeF 16.4 17±1 -6.45±0.04c 13.3 1:20.7 
9 Y48F 15.9 17±2 -6.47±0.09c 14.7 1:20.0 
10 Y48pClF N/A 19±2 -6.41±0.06c 15.2 17.1 
11 Y48pCF3F 7.2 25±2 -6.24±0.1 10.0 1:20.0 
12 Y48pCNF 3.4 43±4 -5.93±0.07c 5.5 1:21.0 
13 Y48pNO2F 1.6 62±6 -5.71±0.1 4.1 1:19.8 
aValues are an average of 3 runs unless otherwise noted. Errors calculated from error values 
given by fitting software. One-site binding used to fit data. bCalculated using the formula ! = [!]!!  
where [M] is the concentration of protein. N=1 is assumed. cAverage of 2 runs. dRatio of 
concentration of protein to ligand.  Higher amounts of H3 ligand needed for accurate curve 
fitting of runs with lower C values (weaker binding proteins). 
 
2.4.2.1 Linear Free Energy Relationships 
 Mutation studies at both positions revealed a linear relationship between σmeta and 
log(Ka), indicating that both of these positions are participating in a tunable cation-π interaction.  
Interestingly, postion 24 shows a greater effect than position 48, implying that the cation-π 
interaction at that residue is stronger (Figure 2.10).   
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Figure 2.10. Plot of log(Ka) vs σmeta values.32 Y48: slope = -0.703, R2 = 0.772; Y24: slope = -1.23, 
R2 = 0.812. 
 While σmeta has been shown to provide a good rough correlation for cation- 
interactions, typically calculated gas phase cation- energies have been used to demonstrate 
cation- energies in linear free energy relationships.6,21   Using values calculated from 
electrostatic potential maps (Figure 2.11), as well as DFT calculations (Figure 2.12) of gas phase 
interactions between Na+ and substituted benzene,28 an even stronger correlation was observed.  
Again, position 24 displays a greater reduction in binding affinity upon incorporation of the 
electron poor aromatic residues, with a slope about two fold less than the slope observed for 
position 48. 
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Figure 2.11. Relationship between log(Ka) of H3K9Me3/HP1 interactions and cation-π binding 
energies calculated using electrostatic potential maps.28 Y24: slope = 0.063, R2 = 0.975; Y48: 
slope = 0.036, R2 = 0.910. 
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Figure 2.12. Plot of log(Ka) vs. cation- gas phase binding energies between Na+ and C6H5X 
calculated by Wheeler and Houk (Eint(C5H6X)).28 Y48: slope = 0.0387, R2 = 0.907; Y24: slope 
= 0.0677, R2 = 0.971. 
 
2.4.2.2 Polarizability  
The data was also plotted against molar refractivity (MR) which is a measure of 
polarizability of the substituents (Figure 2.13).33  The molar refractivity depends on the overall 
polarization of a sample.  By using high frequencies of light, the permanent dipoles of the sample 
cannot rearrange quickly, and the polarization is due to induced polarization from the electric 
field of the light.  Therefore, MR is directly related to polarizability and frequently used as a 
constant to represent differences in polarizability.  Increased polarizability is associated with 
increased ability for the substituent to participate in van der Waals interactions.  As cation-π 
interactions include a VDW component, it is possible that observed effects of mutations could be 
due to changes in polarizability.  While there does appear to be a small correlation between the 
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polarizability of the substituents and their binding affinity, it is in the opposite direction than 
would be expected. If these interactions were contributing significantly, binding affinities are 
expected to increase as this parameter increases, while the observed relationship is a decrease in 
affinity as polarizability increases. 
 
Figure 2.13. Relationship between log(Ka) and polarizability parameter (MR) for Y24X (red) and 
Y48X (blue) mutants. 
2.4.2.3 Hydrophobicity 
 Another noncovelent interaction that could be contributing to this interaction is the 
hydrophobic effect.  The π parameter is often used as a measure of hydrophobicity. The π 
parameter is based on Log P, another parameter frequently used as a measure of hydrophobicity, 
scaled to benzene as 0.34 The P parameter is the partition coefficient of a compound between 
octanol and water.  The more hydrophobic the compound, the greater it partitions into the 
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octanol, and has a higher Log P (and π) value.35  There is no significant correlation between the 
data and π values, indicating changes in the hydrophobic effect are not responsible for the 
variation in binding affinities with variation of the substituent (Figure 2.14).  
 
 
 
Figure 2.14. Relationship between log(Ka) and hydrophobicity parameter (π). 
This data, taken together, strongly indicates the presence of a tunable cation-π interaction 
between both tyrosine positions of HP1 as the main driving force for this interaction. Moreover, 
this demonstrates the first example in which differences in magnitude of two cation-π 
interactions within the same protein binding pocket have been measured using direct binding 
experiments. 
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2.4.3 Surface Plasmon Resonance 
 This trend was confirmed by a second method, using surface plasmon resonance.  In this 
technique, protein is loaded onto the surface of a chip, while a solution of peptide binding 
partners of different concentrations are flown over the immobilized protein for a set injection 
time.  The amount of material loaded onto the chip effects the reflection angle of light shined on 
the chip.  The amount this angle changes upon binding to the peptide at different concentrations 
flowing over the surfaced can be used to calculate a binding constant.  This method uses 
significantly less material that ITC as has the potential for a more high throughput study of 
different peptides.  To confirm that the trend was the same, the mutants at position 48 were used 
and their binding to H3K9Me3 measured (Table 2.4).  The data shown was analyzed using either 
kinetic analysis or equilibrium analysis by the instrument software.  Kinetic analysis calculates 
the on (Kon) rates from the beginning of the injection and the dissociation rate (Koff) after the 
injection ends to then calculate binding affinities.  Equilibrium analysis plots the raw data for the 
different concentrations once the binding is constant to create a binding curve and calculate a 
dissociation constant.  Data shown is from the kinetic analysis. While the overall magnitude of 
the binding constants were different, this can likely be attributed to the different buffer 
conditions needed to perform the experiments. 
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Table 2.4. Binding constants of HP1 mutants measured by SPR 
Entry Protein 
Cation-π 
Energy28 
(kcal/mol) 
Kd (µM)a 
1 Wild Type 15.2 0.89±0.02 
8 Y48F 15.9 1.5±0.02 
9 Y48pCF3F 7.2 2.0±0.02 
10 Y48pCNF 3.4 10b 
11 Y48pNO2F 1.6 5.7±0.04 
aAverage of 3 runs.  Error calculated using standard deviation. baverage of 2 runs; no error 
calculated. 
 
2.4.3.1 Linear Free Energy Relationships 
Despite the different in binding constants, the overall trend and linear relationship remained the 
same (Figure 2.15). 
!
Figure 2.15. SPR data of Y48 HP1mutants plotted against binding energies calculated from 
electrostatic potential maps.28 Errors calculated from standard deviation.  CN data point in 
duplicate, the rest in triplicate. Difference in binding constants attributed to different buffer 
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conditions required for method. Slope = 0.0572, R2 = 0.781. 
 
2.5 Discussion 
 Tryptophan is the aromatic residue most often seen in cation-π interactions6 and also the 
residue that Dougherty has found to be most important in the cation-π recognition of 
acetylcholine,8,9 so it was unclear what kind of effect mutation of tyrosine would have on this 
interaction.  Interestingly, not only do both tyrosine residues participate in a tunable cation-π 
interaction, the data suggests that position 24 is interacting more strongly with the cation than 
position 48.  X-ray structural analysis clearly indicates that differences do not arise from a 
change in structure.   
 By examining the crystal structure of the protein, there are some observations supporting 
these conclusions (Figure 2.16).  Position 24 appears to be centered over two of the partially 
positive methyl groups as well as the methylene, while position 24 appears to be centered over 
just one methyl group.  In a cation-π interaction with trimethyllysine, the alkyl groups are 
typically packed against the aromatic face, as the partial positive charge lies there, and not on the 
nitrogen atom.6 
As this is where the actual partial positive charges of the cation lie, the closer contacts 
with more of the alkyl groups would be expected to provide a stronger interaction.  The actual 
distances observed in the crystal structure confirm this observation, with position 24 having more 
close contacts than position 48 (Figure 2.17). 
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Figure 2.16. Top view of Y24 (left) centered over 2 methyl groups and one methylene compared 
to top view of Y48 (right) centered over one methyl group. 
 
 
Figure 2.17. Distances between tyrosine residues and methyl groups and methylene of 
trimethyllysine. 
 
While there have been several systems studied by this same approach, the vast majority of them 
are functional measurements (either enzyme activities or EC50 values) rather than actual binding 
energy measurements.  Thus, there are not many systems with which to compare the relative 
decrease in binding affinities.  One example measures substituent effects in organic solvent, 
which interestingly resulted in a similar ΔΔG to that observed for the nitro substituent in the Y24 
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mutations (1.4 kcal/mol).36 Many of the studies involving ΔG measurements involve removing 
the cation,  often resulting in a loss of about 2.5 kcal/mol in binding affinity, which is also similar 
to what is observed for HP1.5  Other studies have estimated the strength of a cation-π interaction 
at around 0.5-1 kcal/mol/ring.37 The measured ΔG values measured are in a similar range as 
other methods used to quantify cation-π interactions, however, this is the first time different 
magnitudes of cation-π interactions within the same binding pocket have been directly measured. 
This is the first example of tuning of cation-π interactions in histone reader proteins.  As 
many share a similar aromatic box motif in their binding pocket, further studies can reveal 
whether this is a trend common among other reader proteins, or unique to HP1.  As some reader 
proteins have only a partial formed aromatic box that completely forms upon binding to KMe3, 
they may show different dependences or non-linear relationships, allowing for the potential to 
provide further insights into the binding mechanism of this class of proteins. Detailed 
understanding of the binding mechanism for this class of proteins provides valuable information 
for probe design of these emerging therapeutic targets.  By understanding how a protein 
recognizes its natural substrate with the necessary affinity and selectivity for biological 
processes, we provide a new framework for the design of probes with the necessary affinity and 
selectivity for therapeutic use.  Additionally, computational modeling has become a tool for more 
efficient drug design, this highlights the need for accurately modeling cation-π interactions.  This 
system can provide a useful tool for validating such methods. 
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2.6 Experimental  
2.6.1 Peptide Synthesis.  
2.6.1.1 H3 1-15 for ITC  
H3K9Me3 (ARTKQTARK(Me)3STGGKAY) was synthesized by hand using Fmoc protected 
amino acids and Rink Amide resin on a 0.06 mmol.  The amino acid residues were activated with 
HBTU (O-benzotriazole-N, N, N’, N’,-tetramethyluronium hexafluorophosphate) and HOBT (N-
hydroxybenzotriazole) in the presence DIPEA (diisopropylethylamine) in  DMF (N,N-
dimethylformamide).  Double couplings of 30 minutes each were used.  Deprotections were 
carried out in 20% piperidine in DMF, twice for 15 minutes each.  
 Dimethyllysine was coupled using 2 equivalents of Fmoc-Lys(Me)2-OH HCl for 5 
hours.  Immediately after coupling, the resin was washed with DMF and the residue was 
methylated to form trimethyllysine with 7-methyl- 1,5,7-triaza-bicyclo[4.4.0]dec-5-ene  (MTDB, 
10.8 uL, 0.075 mmol) and methyl iodide (37.4 uL, 0.6 mmol) in DMF (5mL) for 5 hours.  The 
resin was washed with DMF and peptide synthesis was continued as normal. 
Cleavage from the resin was performed in 95:2.5:2.5 trifluoroacetic acid 
(TFA):water:triisopropylsilane (TIPS) for 4 hours.  The TFA was evaporated and products were 
precipitated with cold diethyl ether.  The peptides were extracted with water and lyophilized.  
Peptides were purified by reversed phase HPLC using a C-18 semipreparative column and a 
gradient of 0 to 100% B in 60 minutes, where solvent A was 95:5 water:acetonitrile, 0.1% TFA 
and solvent B was 95:5 acetonitrile:water, 0.1% TFA.  The purified peptides were lyophilized. 
The peptide was desalted for ITC using a Sephadex G-24 column from GE in water and 
lyophilized to a powder and identity was confirmed by MALDI mass spectrometry.  Calculated: 
1765.02 Observed: 1765.95. 
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2.6.1.2 H3 3-15 for Anisotropy 
H3K9Me3 (FAM-TKQTARK(Me)3STGGKA) peptide containing N-terminal 5,6-
carboxyflurosceine (FAM) was synthesized for fluorescence anisotropy using the same 
procedure.  Prior to cleavage from the resin, FAM was coupled to the N-terminus using 2 eq 
FAM, 2 eq PyBOP, 2 eq HOBT, and 4 eq DIPEA.  The coupling was bubbled with N2 overnight 
in a foil wrapped reaction flask and kept in the dark. Cleavage from the resin and purification 
were performed as previously described.  Peptide was used for experiments without desalting, 
and concentration was determined using UV-Vis absorbance of FAM at 492 nm (ε = 78000 M-
1cm-1). 
2.6.2 Circular Dichroism of HP1 Mutants  
CD experiments were performed using an Applied Photophysics Chiroscan Circular 
Dicroism Spectrophotometer.  Spectra were obtained with 30 µM chromodomain in 10 mM 
sodium phosphate buffer, pH 7.4 with dithiothreitol (DTT) 2 mM at 20°C.  All scans were 
corrected by subtracting the buffer.  The mean residue ellipticity was calculated using the 
equation ! = !"#$%&!"!" !! where θ is MRE, signal is CD signal, l is path length, c is protein 
concentration, and r is the number of amino acid residues. 
2.6.3 Fluorescence Polarization Binding Measurements 
Fluorescence polarization measurements were performed using a PolarStar omega plate reader 
by BMG Labtech. Chromodomain solutions of different concentrations were made by 
performing serial half dilutions of a concentrated stock.  Chromodomain (25 µL) was added into 
1 µM FAM labeled peptide (25 µM) in a 96 well plate in 50 mM phosphate buffer, pH 7.4, 25 
mM NaCl, and 2 mM DTT).  Samples were allowed to equilibrate at 25°C for 30 minutes. The 
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samples were analyzed using an excitation wavelength of 485 nm and an emission wavelength of 
520 nm.  The data were analyzed in kaleidegraph using the equation: 
 
where r is fluorescence anisotropy, r0 is the anisotropy of the free histone tail, r∞ is the anisotropy 
of the fully bound histone tail, ρ is the total concentration of histone peptide, |c| is the total 
concentration of chromodomain, and Kd is the dissociation constant.  The variables r0, r∞, and Kd 
were all treated as floating variables. 
 
 
Figure 2.18. Binding curve of Wild Type HP1 titrated into FAM labeled H3K9Me3 peptide 
(FAM-TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate buffer, pH 8, 25 nM NaCl, 2 
mM DTT. 
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5900g, 4 8C). The cells were suspended in NiA buffer (KPO4
(50 mm), NaCl (150 mm), imidazole (5 mm), pH 8.0, 40 mL) and
were lysed with in the presence of DNAse, complete, EDTA-free
protease inhibitor cocktail (Roche Applied Sciences) and PMSF
(final concentration 1 mm). The protein was purified using Ni-NTA
resin with a step gradient of 0–250 mm imidazole using NiA and
NiB buffer (KPO4 (50 mm), NaCl (150 mm), imidazole (250 mm),
pH 8.0). The purity was confirmed by SDS-PAGE and the fractions
were pooled and dialyzed in 100-fold excess of buffer (KPO4
(50 mm), NaCl (25 mm), pH 8.0). The dialyzed protein was concen-
trated using Millipore Centricon filters (5 KDa MWCO).
Circular dichroism: CD measurements were performed on an Aviv
62DS circular dichroism spectrometer. CD data were obtained for
the chromodomain (33.3 mm) in solution containing Na2HPO4
(10 mm), dithiothreitol (DTT, 2 mm), at pH 7.4. Wavelength scans
were performed in triplicate and averaged. Scans were performed
at 25 8C. All scans were corrected by subtracting the spectrum of
the buffer used in the experiment. The mean residue ellipticity
(MRE) was calculated from Equation (1).
V ¼ signal
10 l c
" 1
r
ð1Þ
where V is MRE, signal is CD signal, l is path length, c is protein
concentration, and r is the number of amino acid residues.
Thermal denaturation experiments were preformed using the same
buffer and concentrations as described above and measurements
were taken between 3 8C and 93 8C. The melting curves were nor-
malized to show the fraction folded by using Equation (2).
fraction folded ¼ ðV%VDÞ=ðVF%VDÞ ð2Þ
where V is the observed MRE, VD is the MRE for the fully dena-
tured protein, and VF is MRE for the fully folded protein.
Fluorescence anisotropy: Peptide concentrations were deter-
mined by UV/VIS using the absorbance of 5(6)-FAM (e492=
78000m%1 cm%1). Fluorescence anisotropy measurements were
taken using a PolarStar omega plate reader by BMG Labtech. Sam-
ples were prepared by titrating chromodomain into 1 mm histone
peptides labelled with 5(6)-FAM on the N terminus in buffer (KPO4
(50 mm), NaCl (25 mm), DTT (4 mm), pH 8.0). After allowing the
samples to equilibrate for 30 mi at 25 8C, they were analyzed
using an excitation wavelength of 485 nm and an emission wave-
length of 520 nm at 25 8C. The data were analyzed in Kaleidagraph
by using Equation (3). All binding curves are shown in Figures S1–
S6.
r ¼
!"
pþ ½c( þ KD )
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð%p%½c(%KDÞ2%4ðp " ½c(Þp
2p
$
" ðr1%r0Þ
%
þ r0
ð3Þ
where is fluo escence anisotr py, r0 is the anisotropy of free his-
tone tail, r1 is the anisotropy of fully bound histone tail, p is the
total concentration of fluorescein-labeled peptide, [c] is the total
chromodomain concentration added, and KD is the dissociation
constant. The values for r0, r1, and KD were treated as floating vari-
ables.
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Figure 2.19. Binding curve of HP1 Y24F titrated into FAM labeled H3K9Me3 peptide (FAM-
TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate buffer, pH 8, 25 nM NaCl, 2 mM 
DTT. 
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Figure 2.20. Binding curve of HP1 Y24pClF titrated into FAM labeled H3K9Me3 peptide (FAM-
TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate buffer, pH 8, 25 nM NaCl, 2 mM 
DTT. 
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Figure 2.21. Binding curve of HP1 Y24pCNF titrated into FAM labeled H3K9Me3 peptide 
(FAM-TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate buffer, pH 8, 25 nM NaCl, 2 
mM DTT. 
 
2.6.4 Isothermal Titration Calorimetry Binding Measurements.  
ITC experiments were performed by titrating peptide (2.5-5 mM) into protein (160-250 
µM) in 50 mM sodium phosphate buffer, pH 7, 25 mM NaCl, 2 mM TCEP at 25°C using a 
Microcal AutoITC200.  Peptide concentrations were determined by measuring the UV-Vis 
absorbance at 280 nm, using a NanoDrop2000 with xenon flash lamp, 2048 element linear 
silicon CCD array detector and 1 mm path length.  Heat of dilution subtractions were made using 
the endpoint.  Data was analyzed using a one-site binding model in supplied Origin software.  
Data shown is average of 3 runs unless otherwise noted.  Error is calculated from standard 
deviation unless otherwise noted. 
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Figure 2.22. Wild type: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 5 mM) titrated into protein 
(250 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to one-site 
binding. 
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Figure 2.23. Y24pMeF: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 3 mM) titrated into protein 
(243 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to one-site 
binding. 
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Figure 2.24. Y24F: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 3 mM) titrated into protein 
(160 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to one-site 
binding. 
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Figure 2.25. Y24pClF: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 4.95 mM) titrated into 
protein (250 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to 
one-site binding. 
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Figure 2.26. Y24pCF3F: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 5 mM) titrated into 
protein (250 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to 
one-site binding. 
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Figure 2.27. Y24pCNF: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 5 mM) titrated into protein 
(250 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to one-site 
binding. 
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Figure 2.28. Y24pNO2F: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 5 mM) titrated into 
protein (195 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to 
one-site binding. 
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Figure 2.29. Y48pMeF: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 4.95 mM) titrated into 
protein (239 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to 
one-site binding. 
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Figure 2.30. Y48F: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 5 mM) titrated into protein 
(250 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to one-site 
binding. 
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Figure 2.31. Y48pClF: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 4.95 mM) titrated into 
protein (289 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to 
one-site binding. 
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Figure 2.32. Y48pCF3F: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 5 mM) titrated into 
protein (250 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to 
one-site binding. 
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Figure 2.33. Y48pCNF: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 4.95 mM) titrated into 
protein (236 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to 
one-site binding. 
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Figure 2.34. Y48pNO2F: H3K9Me3 (ARTKQTARK(Me)3STGGKAY; 5 mM) titrated into 
protein (252 μM) at 25°C in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, 2 mM TCEP fit to 
one-site binding. 
 
2.6.5 Surface Plasmon Resonance  
Binding measurements were performed on Proteon XPR36 surface plasmon resonance 
(SPR) based biosensor.  His-tagged Protein was immobilized on a Bio-Rad ProteOn HTG chip 
(containing Nickel-NTA).  Protein was loaded to approximately 800 RU.  Experiments were 
were done in 50 mM sodium phosphate buffer, pH 7.4, 150 mM NaCl, 2 mM TCEP, and 0.005% 
Tween 20 at 25°C.  Binding measurements were done by flowing H3K9Me3 peptide 
(ARTKQTARK(Me)3STGGKAY) at 5 concentrations (10 μM, 5 μM, 2.5 μM, 1 μM, 0.5 μM) 
over chip with immobilized proteins at a flow rate of 100 μL/min for 120 s.  Kinetic analysis of 
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binding data was done using supplied ProteOn software to calculate binding constants.  
Measurements were done in triplicate unless otherwise noted.  
!
 
Figure  2.35. Wild Type kinetic analysis of H3K9Me3 (ARTKQTARK(Me)3STGGKAY) flown 
over immobilized protein at 25°C in 50 mM phosphate buffer, pH 7.4, 150 mM NaCl, 2 mM 
TCEP, 0.005% Tween 20. 
 
Figure 2.36. Y48F kinetic analysis of H3K9Me3 (ARTKQTARK(Me)3STGGKAY) flown over 
immobilized protein at 25°C in 50 mM phosphate buffer, pH 7.4, 150 mM NaCl, 2 mM TCEP 
0.005% Tween 20. 
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Figure 2.37. Y48pClF kinetic analysis of H3K9Me3 (ARTKQTARK(Me)3STGGKAY) flown 
over immobilized protein at 25°C in 50 mM phosphate buffer, pH 7.4, 150 mM NaCl, 2 mM 
TCEP 0.005% Tween 20.  
 
 
 
Figure 2.38. Y48pCF3F kinetic analysis of H3K9Me3 (ARTKQTARK(Me)3STGGKAY) flown 
over immobilized protein at 25°C in 50 mM phosphate buffer, pH 7.4, 150 mM NaCl, 2 mM 
TCEP 0.005% Tween 20. 
 
 
! 69 
 
Figure 2.39. Y48pCNF kinetic analysis of H3K9Me3 (ARTKQTARK(Me)3STGGKAY) flown 
over immobilized protein at 25°C in 50 mM phosphate buffer, pH 7.4, 150 mM NaCl, 2 mM 
TCEP 0.005% Tween 20. 
 
Figure 2.40. Y48pNO2F kinetic analysis of H3K9Me3 (ARTKQTARK(Me)3STGGKAY) flown 
over immobilized protein at 25°C in 50 mM phosphate buffer, pH 7.4, 150 mM NaCl, 2 mM 
TCEP 0.005% Tween 20. 
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CHAPTER 3: SYNTHETIC METHODS FOR PROBING CATION-Π INTERACTIONS 
AT TRYPTOPHAN OF HP1 
 
3.1 Cation-π Interactions at Tryptophan 
 In protein folding and protein-protein interactions, it has been observed that tryptophan 
participates in cation-π interactions with a higher frequency (about 25% of all tryptophans) than 
other aromatic residues.1  They have been shown to be important in protein folding, protein-
protein interactions, and interactions with membranes. The importance of one cation-π 
interaction at tryptophan has been observed in ligand gated ion channels. In binding regions 
containing multiple aromatic residues, it has often been found that a single tryptophan 
participates in a tunable cation-π interaction.2,3 
3.1.1 Tuning Tryptophan Cation-π interactions  
 
 
Figure 3.1. Electrostatic potential maps of tryptophan (left) difluorotryptophan (middle) and 
tetrafluorotryptophan. Electrostatic potential maps were generated with MacSpartan: HF/6-
31G*; isodensity value = 0.02; range = -50 (red, electron rich) to 50 kcal/mol (blue, electron 
poor). 
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Incorporating fluorine atoms around the indole ring of the tryptophan has been the 
method most often used for studying these interactions (Figure 3.1).  Systematic fluorination 
provides a method to incrementally tune the electronics of the ring. Tetrafluoroindole (and 
trifluorophenylalanine) has been used to completely eliminate the electrostatic component of the 
cation-π interaction, and can be used to potentially quantify the interaction at specific tryptophan 
residues.1,4,5  Using this method, replacement of tryptophan residues with tetrafluorotryptophan 
has led to a 50 to 500 fold decrease in activity, which can be estimated as up to a –ΔG of 3.7 
kcal/mol if binding affinities change by the same ratio as activies.1  The largest magnitude 
observed in receptors of this type is a –ΔG of 5.5 kcal/mol in a glycine binding receptor.1 
Due to the membrane bound nature of systems studied, functional assays rather than 
binding measurements have been performed in studies of ligand-gated ion channels.  This can be 
done on single cells, and much less material is used than is required for binding measurements. 
To incorporate these amino acids, stoichiometric tRNA already loaded with the desired amino 
acid need to be used.  Traditional unnatural amino acid mutagenesis methods have not yet been 
developed for fluorinated tryptophan, as they are too similar to natural tryptophan and will be 
recognized by the native synthetase and get incorporated into any proteins naturally containing a 
tryptophan, as well as all AChR tryptophan residues.  In the reader protein heterochromatin 
protein 1 (HP1), we have shown that two of the tyrosine residues participate in cation-π 
interactions to different extents; however, to study tryptophan alternative methods need to be 
developed.  
 Synthetic methods for the incorporation of fluorinated tryptophan (as well as methods for 
synthesizing the amino acid itself) are needed for the study of binding interactions at this 
position.  Knowing the contribution of tryptophan to cation-π interaction can help provide a more 
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detailed description of the mechanism reader proteins use to recognize their substrates.  This can 
aid in the design of developing therapeutics with the necessary affinity and selectivity.  
3.2 Synthesis of Fluorinated Tryptophan 
 While fluorinated tryptophans are commercially available, many are only available as the 
racemic mixture, or they are prohibitively expensive.  Thus, synthetic methods for accessing the 
desired tryptophan residues were pursued with two undergraduate researchers, Nathan John and 
Kaitlyn Tsai.    
3.2.1 Synthesis of Alkyl Bromide Side Chain 
 While there are several methods for accessing the chiral amino acids, many of them 
require the alkyl bromide derivative of the side chain.  Previously reported methods for the 
synthesis of fluorotryptophan beginning with the corresponding indole worked nicely for mono, 
di, and tetrafluoroindole (scheme 3.1).6 
 
Scheme 3.1. Synthesis of alkyl bromide for tryptophan synthesis starting with the corresponding 
indole. 
 
 Vilsmeier-Haack formylation of the indole was used to install the aldehyde, while the 
corresponding aldehyde of tetrafluoroindole was commercially available.  Subsequent protection 
of the indole with a tosyl group, and reduction of the aldehyde to the alcohol proceded cleanly 
and in high yields.  Conversion of the alcohol to the corresponding bromide gave the desired 
1" 2
"
3"
4" 5"
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alkylating agent for amino acid synthesis.  Large quantities were stored as the alcohol, as the 
bromide was less stable and more difficult to work with as it was a moderate lachrymator when 
completely free of solvent. 
3.2.2 Asymmetric Alkylation 
 Several strategies were employed for the asymmetric alkylation of glycine with the 
desired side chain.  Previous work in our lab had used the pseudoephedrine auxiliary for the 
asymmetric synthesis of amino acids.7  However, when trying to use this approach, low yields of 
coupling the auxiliary to glycine led to the exploration of other methods.  Use of the Schöllkopf 
auxiliary proved to be more amenable to the tryptophan synthesis (Scheme 3.2).6  The auxiliary 
is essentially the dimer of glycine and valine, with the isopropyl group of the valine providing 
the chiral directing group for the reaction.  The lithiation and alkylation proceeded in moderate 
yields.  Subsequent acid and base hydrolysis revealed the tryptophan residue. 
 
Scheme 3.2. Synthesis of tryptophan derivatives using the Schöllkopf auxiliary.6 
44% 
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 Additional methods showed promise, though were subsequently abandoned in favor of 
the Schöllhopf method.  They may, however, be useful in the synthesis of other amino acids in 
future studies. 
 Most notably, the use of proline derived nickel complexes was explored.8,9  The method 
was appealing due to the potential of reusing the nickel complex after acid hydrolysis to release 
the desired amino acid (Scheme 3.3).  The complex exhibits a characteristic bright red color, 
making purification easier as well.   
 
Scheme 3.4. Synthesis of proline derived nickel complex. 
Benzylation of proline was done with benzyl chloride in the presence of sodium 
methoxide.  Aminobenzophenone was coupled to the proline to provide the chiral framework.  
Glycine could then be condensed on and the structure could be complexed with Ni2+ to from the 
bright red crystalline solid for further amino acid synthetic studies. 
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Asymmetric alkylation was not further pursued, as previous methods were sufficient for 
amino acid synthesis.  However, the alkylation could be done as described in the literature 
(scheme 3.5), and may be useful for future synthesis of amino acid derivatives. 
 
Scheme 3.5. Asymmetric alkylation of proline derived nickel complex followed by release of the 
amino acid. 
 
3.3  Native Chemical Ligation 
3.3.1 Background 
While proteins for studies like this are often made by cellular expression of the protein, 
the HP1 chromodomain consists of around 70 residues, making it amenable to synthetic 
methods.10 To avoid the potential low yields and difficult purification anticipated with linear 
synthesis, initial studies looked at ligation techniques that can be employed, such as native 
chemical ligation.11   
This technique allows for the ligation of two shorter peptides into one long peptide 
containing the native peptide bond at the ligation site (Scheme 3.6).  The ligation requires one 
peptide to have a thioester at the C-terminus, while the other peptide has a free amine at the N-
terminus with a thiol containing amino acid (typically cysteine).  The thiol of the cysteine reacts 
with the thioester. This brings the free amine in close proximity, allowing for S to N acyl transfer 
to occur, resulting in a native peptide bond.  This method has been successful in synthesizing 
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many large peptides that would have been difficult with linear synthesis. 
 
Scheme 3.6. Native chemical ligation between peptide with C-terminal thioester (peptide 1) and 
N-terminal cysteine (peptide 2). 
 
One of the main disadvantages of this approach is the necessity of a naturally occurring 
cysteine positioned at a site well suited for breaking apart the peptide.  Cysteine has a natural 
abundance of about 1.2%, limiting the number of proteins for which this approach is useful.12 
There are several ways to expand the scope of this ligation.  The simplest is to mutate a residue 
in the peptide to a cysteine.  Alternatively, if there is no residue that can be mutated without 
changes in structure or function, using a thiol derivative on an amino acid followed by a 
desulfurization reaction can greatly increase the possible sites.  This has been used successfully 
for ligations at alanine,13 valine,12 leucine,14 threonine,15 lysine,16 phenylalanine,17 and proline.18   
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3.3.2 NCL of HP1 
Residues 22-76 of the HP1 chromodomain are structured based on the x-ray structure 
data (Figure 3.2). 
 
 
 
Figure 3.2. Crystal structure of HP1 (top) with proposed sites of mutation to cysteine for ligation 
in purple. Sequence of HP1 (bottom – residues 22-76) with proposed ligation mutations in red 
and binding pocket residues in blue. 
 
 As the domain does not naturally contain any cysteine residues, sites for potential 
mutations were identified.  Both threonine 51 and methionine 38 were identified as potential 
sites as they split the peptide into manageable fragments, and were not expected to cause drastic 
structural changes after mutation to cysteine as they are both solvent exposed, and the side chains 
A) EEYAVEKIIDRRVRKGMVEYYLKWKGYPETENTWEPENNLDCQDLIQQYEASRKD 
B) EEYAVEKIIDRRVRKGMVEYYLKWKGYPECENTWEPENNLDCQDLIQQYEASRKD 
C) EEYAVEKIIDRRVRKG C VEYYLKWKGYPETENTWEPENNLDCQDLIQQYEASRKD 
! 81 
do not appear to be engaging in any interactions important for protein folding. Synthesis of the 
fragments for the T51C mutation was synthetically problematic, as premature truncation 
products were always observed and could not be avoided after screening many different 
conditions including added salts, and different coupling reagents. The M38C mutation was 
pursued further as it was synthetically less challenging. 
 The full length HP1 was expressed with the M38C mutation and fluorescence anisotropy 
was used to confirm the chosen mutation did not affect binding of the natural substrate in any 
way (Figure 3.3).  The Kd of the M38C mutant was measured to be 22 µM, which is within error 
of the 20 µM previously measured for wild type. 
 
Figure 3.3. Binding curve of M38C HP1 titrated into FAM labeled H3K9Me3 peptide (FAM-
TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate buffer, pH 8.0, 25 nM NaCl, 2 mM 
DTT. 
!
! 82 
3.3.2.1 Thioester Fragment  
Synthesis of the thioester fragment of HP1 was based on a method previously used.19 In 
order to synthesize the thioester at the C-terminus, the peptide needed to be cleaved from the 
resin with the side chain protecting groups still in place.  To achieve this, 2-chlorotrityl chloride 
resin was used (Scheme 3.7). Purchasing preoaded resin often gave cleaner peptide, but the first 
amino acid could be loaded on the resin immediately prior to synthesis as well.  Synthesis of the 
fragment was carried out using standard solid phase peptide synthesis with Fmoc protected 
amino acids.  After capping the N-terminus with acetic anhydride, the protected peptide fragment 
could be cleaved from the resin using 1% TFA, and the C-terminal acid could be coupled with a 
thiol to form a C-terminal thioester for ligation.  To avoid premature deprotection of side chains, 
1 equivalent DIPEA (relative to amount of TFA in cleavage mixture) was added to the flask into 
which the peptide was drained.  This immediately quenched the TFA so the peptide was not 
exposed to acid any longer than necessary for cleavage.  After installing the thioester, the peptide 
could be fully deprotected and purified as normal.  Care was taken to insure the peptide was not 
left in solution for any extended periods of time and that any solution was relatively acidic to 
prevent hydrolysis of the thioester. 
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Scheme 3.7. Synthesis of the thioester fragment. 
 
3.3.2.2 Aspartamide Formation  
 One of the main side reactions encountered in the synthesis of HP1 was aspartamide 
formation (Scheme 3.8).  During the deprotection steps the side chain of aspartic acid can cyclize 
with the backbone amide.   
 
Scheme 3.8. Aspartimide side reaction occurring during deprotection. 
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by buffering the deprotection solution.  Using this method of deprotection, both fragments could 
be consistently synthesized and purified in large quantities. 
3.3.2.3 Ligation  
 Ligation reactions were performed under commonly used conditions with 
mercaptophenylacetic acid (MPAA).as a catalyst.20  This catalyst has been shown to form a more 
reactive thioester for the ligation reactions.  The use of this catalyst initially caused difficulty in 
monitoring the reaction by reverse phase HPLC in TFA buffered solvents as the peak overlapped 
with the peptide fragments.  By switching to ammonium acetate buffer for HPLC monitoring the 
peptide products could be separated from the MPAA catalyst and monitored (Figure 3.4). 
 
 
Figure 3.4.  Analytical HPLC trace of peptide fragments in ligation buffer: 100mM phosphate, 6 
M guanidinium HCl, 5 0mM MPAA, 20 mM TCEP at 280 nm. 
 
 Under these conditions, a new peak grew in and complete conversion was observed after 
12 hours at room temperature.  In addition to HPLC, the crude reaction mixture was monitored 
by MALDI mass spec, and the mass corresponding to the ligated product was also observed after 
12 hours (Figure 3.5). 
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Figure 3.5.  MALDI mass spec of crude ligation reaction with mass corresponding to ligated 
produce (circled). 
 
 The new peak in the HPLC trace of the ligation reactions was analyzed by LC-MS to 
confirm the identity of the ligated product (Figure 3.6). 
 
Figure 3.6.  LC-MS of peak collected from ligation reactions showing the M+5, M+6, and M+7 
peaks. 
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 With the conditions for ligation and purification worked out for HP1, ligation reactions 
on larger scales were needed in order to synthesize enough protein for binding measurements.  
Unfortunately, upon injection of the reactions onto a preparatory HPLC, the ligation reactions 
appeared to behave differently than the small scale injections on the analytical HPLC, potentially 
due to aggregation issues (Figure 3.7).  Using this method, isolation of enough protein from the 
ligation reaction was not possible. 
 
Figure 3.7. HPLC trace of large scale (5 mL reaction volume) ligation reaction. 
 
3.4 SPPS of HP1 
 In addition to synthesizing HP1 by native chemical ligation, efforts to synthesize the 
protein linearly were pursued.  Small amounts of protein were observed by mass spectrometry 
during linear synthesis at room temperature on a synthesizer using standard HBTU/HOBt 
coupling conditions, suggesting with some optimization, linear synthesis of HP1 might be 
feasible.  To improve and simplify purification, an approach for easily purifying protein from 
deletion products was developed (Figure 3.8).  Common side products are single amino acid 
deletions were coupling steps were incomplete.  A common method for simplifying purification 
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is to acetylate after each coupling steps, so peptide chains that have not been coupled to the next 
amino acid are truncated.  Truncation products have a vastly different size and charge than fully 
synthesized chains, and are often much easier to purify by HPLC.  To take advantage of this 
method further, a tag can be coupled as the last step of the synthesis, in this case, a series of 6 
histidine residues.  This allows for affinity chromatography (in this case a Ni-NTA column) to be 
used to purify out the fully synthesized protein.  Because incomplete coupling steps were 
truncated, only protein that has been successfully coupled with each amino acid will have the 
poly-histidine tag.  The Ni-NTA column can be used to pull out only the full length HP1, greatly 
simplifying isolation of the synthetic product.  
 
Figure 3.8. Cartoon of example of types of products in crude peptide mixture (left) that can 
easily be purified out (right). 
 
 The synthesis itself was also further optimized by the CEM corportation based on 
previously published high-efficiency peptide synthesis.21  This method uses activation with 
diisopropylcarbodiimide (DIC) and ethyl(hydroxyimino)cyanoacetate (Oxyma).  These 
conditions allow for higher temperatures for more efficient couplings and reduced waste and 
coupling times.  Using this method, CEM was able to achieve approximately 70% crude purity 
by LCMS analysis on a LibertyBLUE Microwave peptide synthesizer (Figure 3.9).  On a 
Liberty1 peptide synthesizer in our lab, the yields are not as high, but enough protein for 
experiments was synthesized by this method. 
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Figure 3.9. UPLC-MS trace of synthetic HP1 from CEM Corporation.  
 
 
3.5  Binding measurements of HP1 
 With Stef Baril in the Brustad Lab, the synthetic HP1 was purified via FPLC with a Ni-
NTA column followed by size exclusion chromatography.  The isolated protein was then 
concentrated into buffer for the fluorescence anisotropy buffer that had been previously used for 
binding measurements with expressed HP1.  The synthetic chromodomain was titrated into 
H3K9Me3 peptide containing an N-terminal FAM tag and the binding affinity was measured by 
fluorescence anisotropy experiments (Figure 3.10). 
 
CEM Corporation ● PO Box 200 ● Matthews, NC 28106 ● (800) 726-3331 ● (704) 821-7015 ● www.cempeptides.com 
5. Cleavage: TFA/TIS/H2O/DODT (92.5/2.5/2.5/2.5); 30 min at 38 oC 
6. UPLC-MS Analysis: Crude Purity approx. 70%; product signal at RT = 5.94 min:  
 
 
MS for signal at RT = 5.94 min: 
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Figure 3.10. Binding curve of synthetic HP1 titrated into FAM labeled H3K9Me3 peptide (FAM-
TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate buffer, pH 8.0, 25 nM NaCl, 2 mM 
DTT. Kd = 5µM. 
 
 These experiments confirmed that the synthetic protein was functional, as it bound to its 
natural substrate.  The measure binding constant was 5 µM, which was tighter than the 20 µM 
measured for wild type.  This difference may be attributed to the inconsistencies observed for 
fluorescence anisotropy experiments with HP1.   
 To test this method with unnatural amino acids, initial studies were done at tyrosine 48 
with pentafluorophenylalanine (Y48F5F).  The fluorinated alanine derivatives are commercially 
available and provide a good test of this method before use of synthesized tryptophan derivatives 
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were incorporated.  However, binding to this synthetic mutant was very weak (Figure 3.11), and 
the curve produce was could not be accurately analyzed.   
 
Figure 3.11. Binding curve of synthetic HP1 containing Y48F5F mutation titrated into FAM 
labeled H3K9Me3 peptide (FAM-TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate 
buffer, pH 8.0, 25 nM NaCl, 2 mM DTT. 
 
3.6 Discussion 
 Promising synthetic methods have been developed for accessing HP1 via solid phase 
peptide synthesis.  The synthetic protein was demonstrated to be functional but measured binding 
to the trimethyllysine containing H3 peptide.  This approach will allow for the site specific 
incorporation of unnatural amino acids.  The method for simplifying purification also has the 
potential for the use of smaller amounts of unnatural amino acid in coupling reactions.  If the 
amino acid is extremely expensive, or difficult to synthesize, the use of less than 5 equivalents is 
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still useful for synthesis, even if the coupling is difficult. Instead of deletion products if coupling 
is not complete, the peptide will truncate and only peptide chains that have incorporated the 
amino acid will continue through the synthesis and have the his-tag attached.  This not only 
simplifies purification, but also provides a preliminary screen for coupling of the unnatural 
amino acid – some of which can be more difficult to couple than natural amino acids.   
 Incorporation of F5F amino acid appeared to be successful based on isolation of material 
from his-tag purification, however the protein did not produce a binding curve that could be 
accurately analyzed.  It is possible that the mutation weakened electrostatics significantly and 
disrupted binding significantly.   
 Further work to obtain CD spectra and mass spec data of synthesized mutants will be 
needed to ensure the proper protein is being synthesized and that the protein is well folded.  
Other methods can be used for determination of binding affinities that have proven to be more 
reliable for HP1 such as isothermal titration calorimetry (ITC) or surface plasmon resonance 
(SPR).   
 Studying the contribution of tryptophan will give a complete analysis of the cation-π 
interactions of all positions in the binding pocket of HP1.  This detailed understanding will 
provide information about how the protein recognizes it’s native substrates, which will aid in 
developing probes for proteins of this type.  Further, this work provides a general approach for 
synthetically mutating proteins and potentially expanding the scope of proteins that can be 
synthesized linearly by solid phase peptide synthesis.  With the incorporation of acetyl capping 
after coupling steps and an N-terminal affinity tag, proteins with small yields and in complex 
mixtures of side products from the synthesis should be easily to isolate and purify by affinity 
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chromatography.   This will allow for simpler mutation studies of proteins that are not easily 
amenable to expression technologies. 
3.7 Experimental 
3.7.1 Procedure for Synthesis of Fmoc Fluorotryptophan  
Synthesis based on literature procedure.6 
3.7.1.1 Synthesis of Compound 2 
 
Phosphoryl chloride (1.4 mL, 14.8. mmol, 2 eq) was dissolved in 3 mL dimethyl formamide and 
cooled in an ice bath for 15 minutes.  A solution of the indole 1 (1 g, 7.4 mmol) in 77 mL 
dimethyl formamide was added dropwise to the phosphoryl chloride solution and stirred at 0° C 
for 15 minutes. The reaction was heated to 40° C for 1.5 hours, until an opaque solid formed.  Ice 
chips were added to the mixture until the solution became homogenous.  Sodium hydroxide (5%) 
was added until the pH of the mixture was greater than 10.  The reaction was refluxed for 5 
minutes.  After cooling the mixture to room temperature, the mixture was extracted with ethyl 
acetate, dried with anhydrous magnesium sulfate and concentrated in vacuo to a brown liquid.  
The crude product was used without further purification.  1H NMR (400 MHz, CDCl3) δ 7.125 
(m, 1H), 7.54 (m, 1H), 7.77 (dd, 1H), 8.36 (d, 1H), 9.93 (s, 1H, CHO). 
 
 
 
2
"
1
"
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3.7.1.2 Synthesis of Compound 3 
 
Aldehyde 2 (7.4 mmol; crude) was dissolved in 70 mL tetrahydrofuran and cooled to 0° C in an 
ice water bath. Sodium hydride (60% in mineral oil, 11.1 mmol, 1.5 eq) and tosyl chloride (8.1 
mmol, 1.1 eq) was added to the reaction.  The mixture was allowed to warm to room temperature 
and stirred overnight.  The reaction was quenched with saturated ammonium chloride solution 
and concentrated.  The residue was partitioned between ethyl acetate and water, and the aqueous 
layer was further extracted with ethyl acetate.  The organic layers were combined, dried with 
magnesium sulfate and concentrated to a light yellow solid.  The crude product was purified by 
column chromatography on silica gel with 2:1 hexanes:ethyl acetate.  The purified product was 
isolated as a white solid. (68% over 2 steps). 1H NMR (400 MHz, CDCl3) δ 2.42 (s, 3H), 7.16 
(m, 1H), 7.34 (d, 2H), 7.86 (d, 2H), 7.94 (m, 1H), 8.27 (s, 1H), 10.09 (s, 1H, CHO). 
 
3.7.1.3 Synthesis of Compound 4 
 
Protected aldehyde 3 (1.58 g, 5.0 mmol) was dissolved in 2:1 tetrahydrofuran:ethanol (32 mL:16 
mL) and cooled to 0° C in an ice water bath.  Sodium borohydride (7.5 mmol, 1.5 eq) was added.  
The mixture was allowed to warm to room temperature and was stirred overnight.  The reaction 
was quenched with saturated aqueous ammonium chloride and concentrated in vacuo.   The 
2
"
3
"
3
" 4
"
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residue was dissolved in brine and extracted with dichloromethane.  The organic layers were 
combined, dried with MgSO4 and concentrated in vacuo.  The crude product was purified by 
silica-gel column chromatography with 2:1 hexanes:ethyl acetate and isolated as a white solid 
(95%). 1H NMR (400 MHz, acetone) δ 2.37 (s, 3H), 4.76 (s, 2H), 7.16 (m, 1H), 7.39 (m, 1H), 
7.40 (d, 2H), 7.70 (s, 1H), 7.88 (d, 2H), 8.03 (m, 1H). 
 
3.7.1.4 Synthesis of Compound 5 
 
Alcohol 4 (500 mg, 1.57 mmol) was dissolved in 20 mL dichloromethane and cooled to 0° C in 
an ice water bath.  Triphenylphosphine (1.72 mmol, 1.1 eq) was added.  After 10 minutes n-
bromosuccinimide (1.72 mmol, 1.1 eq.) was added to the mixture and maintained at 0° C for 1 
hour.  The ice water bath was then allowed to warm to room temperature and the reaction stirred 
overnight.  The reaction was concentrated in vacuo and the residue was run through a short plug 
of silica-gel using 4:1 hexanes:ethyl acetate.  The solution was concentrated in vacuo and used 
without further purification (81%). 1H NMR (400 MHz, acetone) δ 2.38 (s, 3H), 4.86 (s, 2H), 
7.22 (m, 1H), 7.42 (d, 2H), 7.47 (m, 1H), 7.91 (d, 2H), 8.01 (s, 1H), 8.05 (m, 1H). 
 
 
 
 
 
4 5
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3.7.1.5 Synthesis of Compound 6 
 
The chiral auxiliary (Schöllkof reagent) (316 mL, 1.76 mmol) was dissolved in 10 mL THF and 
cooled to -78° C in an isopropyl alcohol/dry ice bath.  Freshly titrated n-butyllithium (2 mL, 
1.623 M in hexanes, 2 eq.) was added to the reaction mixture and allowed to stir for 1 hour.  The 
alkyl bromide was dissolved in 10 mL THF and added to the mixture dropwise.  The reaction 
was allowed warm to room temperature and stirred overnight.  The reaction was quenched with 
saturated aqueous ammonium chloride and solvents removed in vacuo.  The residue was 
dissolved in brine and extracted with dichloromethane.  The organic layers were combined and 
dried with MgSO4 and concentrated in vacuo.  The crude product was purified by silica-gel 
column chromatography with 18:1 chloroform:ethyl acetate resulting in a colorless oil (44%). 1H 
NMR (400 MHz, CDCl3) δ 0.615 (d, 3H), 0.877 (d, 3H), 2.08 (m, 1H), 2.35 (s, 3H) 3.11 (m, 1H) 
3.12 (m, 1H), 3.18 (m, 1H), 3.66 (s, 3H), 3.69 (s, 3H), 4.32 (m, 1H), 6.98 (m, 1H), 7.19 (dd, 1H), 
7.21 (d, 2H,) 7.31 (s, 1H), 7.67 (d, 2H), 7.87 (m, 1H). 
 
3.7.1.6 Synthesis of Compound 7 
 
44% 
59%
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The alkylated Schöllkopf reagent (0.193 g, 0.39 mmol) was dissolved in  6 mL THF and cooled 
to 0° C in an ice water bath.  To the mixture, 2 N HCl (3.2 mL) was added.  The mixture was 
warmed to room temperature after 10 minutes and allowed to stir for 1 hour.  The THF was 
removed in vacuo and the aqueous solution diluted with water.  The product was neutralized by 
adding ammonium hydroxide until the pH reached 10.  The mixture was extracted with ethyl 
acetate and dried with MgSO4.  The solvent was removed in vacuo and residue purified by silica-
gel column chromatography using 5% methanol, 0.5% ammonium hydroxide in ethyl acetate.  
The product was isolated as a colorless oil (59%). 1H NMR (400 MHz, CDCl3) δ 2.078 (s, 3H), 
2.69 (m, 1H) 2.84 (m, 1H), 3.19 (s, 3H), 3.87 (m, 1H), 6.78 (m, 1H), (dd, 1H), 6.97 (d, 2H), 7.25 
(s, 1H), 7.47 (d, 2H), 7.65 (m, 1H). 
 
3.7.1.7 Synthesis of Compound 8 
 
Fluorotryptophan methyl ester (127 mg, 0.33 mmol) was dissolved in 3.6 mL ethanol and 2.2 mL 
2 N sodium hydroxide added.  The reaction was heated at reflux for 30 minutes.  The solution 
was cooled to room temperature and 6N HCl added until the pH reached 2.  The solution was 
extracted with dichloromethane.  Sodium hydroxide was added until the pH reached 6 and the 
water was removed in vacuo.  The residue could be either carried forward crude, or purified by 
recrystallization in ethanol/water to give a white to tan solid and stored as purified amino acid 
(82%). 1H NMR (400 MHz, D2O) δ 3.17 (m, 1H), 3.32 (m, 1H), 3.92 (m, 1H), 6.94 (m, 1H), 7.24 
(s, 1H), 7.29 (m, 1H), 7.36 (m, 1H). 
82% 
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3.7.1.8 Synthesis of Compound 9 
 
 
Fluorotryptophan (73 mg, 0.33 mmol) was dissolved in 7 mL of a 50/50 solution of sat. NaHCO2 
and acetonitirile. Fmoc-OSu (135 mg, 0.40 mmol) was added.  The reaction mixture was stirred 
for 3 hours.  HCl was added until the pH reached 7 and the solvents were removed under 
vacuum.  The residue was purified by silica gel chromatography using 5% methanol in 
chloroform. 1H NMR (400 MHz, Acetone) δ 3.22 (m, 1H), 3.38 (m, 1H), 4.22 (m, 1H), 4.45 (m, 
2H), 4.58 (m, 1H), 6.90 (m, 1H), 7.38-7.28 (m, 7H, overlap) 7.64 (m, 2H), 7.84 (d, 2H). 
 
3.7.2 Peptide Synthesis 
3.7.2.1 Synthesis of the C-terminal Fragment 
C-terminal NCL Fragment HP1 (residues 38-76) 
(CVEYYLKWKGYPETENTWEPENNLDCQDLIQQYEASRKD) was synthesized on a CEM 
Liberty1 Microwave Peptide Synthesizer using Fmoc protected amino acids and CLEAR Amide 
resin. The amino acid residues were activated with HBTU (O-benzotriazole-N, N, N’, N’,-
tetramethyluronium hexafluorophosphate) in the presence of DIPEA (diisopropylethylamine) in 
DMF (N,N-dimethylformamide).  Double couplings of 5 minutes each were used.  Deprotections 
were carried out in 6% piperizine and 0.1 HOBt (hydroxy benzyl triazole) in DMF, twice for 45 
8
9
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seconds each.  The peptide was acetylated with acetic anhydride and 2,6 lutidine in DMF after 
every coupling to cap any unreacted peptide chains.  The N-terminus of the final cysteine residue 
was left unprotected.   Cleavage from the resin was performed in 94:2.5:2.5:1 trifluoroacetic acid 
(TFA):ethanedithiol (EDT):water:triisopropylsilane (TIPS) for 3.5 hours.  The TFA was blown 
off with nitrogen and products were precipitated with cold diethyl ether.  The peptides were 
extracted with water and lyophilized.  Peptides were purified by reversed phase HPLC using a C-
18 semipreparative column and a gradient of 0 to 100% B in 60 minutes, where solvent A was 
95:5 water:acetonitrile, 0.1% TFA and solvent B was 95:5 acetonitrile:water, 0.1% TFA.  The 
purified peptides were lyophilized and identity was confirmed by ESI mass spectrometry. 
Calculated: [M+H+]: 4797, [M+2H+]: 2399, [M+3H+]: 1599.6, [M+4H+]: 1200; Observed: 
[M+3H+]: 1600.14, [M+4H+]: 1200.87 
3.7.2.2 Synthesis of Thioester Fragment 
N-terminal Thioester Fragment of HP1 (residues 22-37) (EEYAVEKIIDRRVRKG)The 
thioester fragment was synthesized on an Applied Biosystems Pioneer Peptide Synthesizer using 
Fmoc protected amino acids and 2-chlorotrityl chloride resin.  The first amino acid was 
preloaded on the resin using 2 equivalents amino acid, 4 equivalents DIPEA in 5 mL 
dichloromethane twice, for 1 hour each.  Preloaded resin can also be purchased, but for NCL 
fragment synthesis, the residue was most often loaded by hand.  Subsequent amino acid residues 
were coupled with HBTU (O-benzotriazole-N, N, N’, N’,-tetramethyluronium 
hexafluorophosphate) and HOBT (N-hydroxybenzotriazole) in the presence of DIPEA 
(diisopropylethylamine) in solvent DMF (N,N-dimethylformamide) on an Applied Biosystems 
automated peptide synthesizer.  Double couplings of 30 minutes each were used.  Deprotections 
were carried out in 6% piperizine and 0.1 HOBt (hydroxy benzyl triazole) in DMF, twice for 15 
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minutes each. The fully protected peptide fragment was cleaved from the resin using 3mL of 1% 
TFA in dichloromethane 3 times for three minutes each.  The cleavage mixtures were drained 
into a flask containing 1 equivalent diisopropyl ethyl amine, and concentrated in vacuo to a 
yellow oil.  The concentrated peptide was dissolved in 3.5 mL DMF.  The thioester was formed 
by adding 4 equivalents DIPEA, 4 equivalents methyl thioglycolate and 4 equivalents PyBOP for 
1 hour.  The DMF was removed via high vacuum. Peptide deprotection was performed in 
94:2.5:2.5:1 trifluoroacetic acid (TFA):ethanedithiol (EDT):water:triisopropylsilane (TIPS) for 
3.5 hours.  The TFA was evaporated and products were precipitated with cold diethyl ether.  The 
peptides were extracted with water and lyophilized.  Peptides were purified by reversed phase 
HPLC using a C-18 semipreparative column and a gradient of 0 to 100% B in 60 minutes, where 
solvent A was 95:5 water:acetonitrile, 0.1% TFA and solvent B was 95:5 acetonitrile:water, 
0.1% TFA.  The purified peptides were lyophilized and identity was confirmed by ESI mass 
spectrometry. Calculated: [M+H+]: 2091, [M+2H+]: 1046, [M+3H+]: 967.7; Observed: [M+2H+]: 
1046.04, [M+3H+]: 967.87. 
3.7.2.3 Synthesis of Full Length HP1 with His-tag.   
 (MKKHHHHHHAEEEEEEYAVEKIIDRRVRKGKVEYYLKWKGYPETENTWEPEN
NLDCQDLIQQYEASRKD) Full length HP1 was synthesized on a CEM Liberty1 Microwave 
Peptide Synthesizer using Fmoc protected amino acids and Rink Amide resin. The amino acid 
residues (5 eq) were activated with DIC (diisopropylcarbodiimide – 5 eq) in the presence of 
Oxyma (Ethyl (hydroxyimino)cyanoacetate – 5 eq).  Double couplings of 4 minutes each at 90° 
C were used.  Arginine and histidine residues were coupled at RT for 4 min and 50° C for 8 min. 
Deprotections were carried out in 10% piperazine and 0.1 HOBt (hydroxy benzyl triazole) in 9:1 
NMP:EtOH, twice for 60 seconds each at 90° C.  The peptide was acetylated with acetic 
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anhydride and 2,6 lutidine in DMF after every coupling to truncate any unreacted peptide chains.  
Cleavage from the resin was performed in 92.5:2.5:2.5:2.5 trifluoroacetic acid (TFA): 
(ethylenedioxy)diethanethiol (DODT):water:triisopropylsilane (TIPS) for 3.5 hours.  The TFA 
was blown off with nitrogen and products were precipitated with cold diethyl ether.  The 
peptides were extracted with water and lyophilized.  His-tagged protein was purified by FPLC on 
a Ni-NTA column, followed by size exclusion chromatography and concentrated in an 
appropriate buffer for experiments.Protein was confirmed by LC-MS. Calculated: [M+H+]:  
8434, [M+5H+]: 1688, [M+6H+]: 1407, [M+7H+]: 1206; Observed: [M+5H+]: 1688.44, 
[M+6H+]: 1407.32, [M+7H+]: 1206.61. 
3.7.2.4 Synthesis of H3 1-15 K9Me3   
H3 1-15 for SPR containing KMe3 at position 9 (ARTKQTARK(Me)3STGGKAY) was 
synthesized by hand using Fmoc protected amino acids and Rink Amide resin on a 0.06 mmol 
scale.  The amino acid residues were activated with HBTU (O-benzotriazole-N, N, N’, N’,-
tetramethyluronium hexafluorophosphate) and HOBT (N-hydroxybenzotriazole) in the presence 
DIPEA (diisopropylethylamine) in  DMF (N,N-dimethylformamide).  Double couplings of 30 
minutes each were used.  Deprotections were carried out in 20% piperidine in DMF, twice for 15 
minutes each.  
 Dimethyllysine was coupled using 2 equivalents of Fmoc-Lys(Me)2-OH HCl for 5 
hours.  Immediately after coupling, the resin was washed with DMF and the residue was 
methylated to form trimethyllysine with 7-methyl- 1,5,7-triaza-bicyclo[4.4.0]dec-5-ene  (MTDB, 
10.8 uL, 0.075 mmol) and methyl iodide (37.4 uL, 0.6 mmol, 10 equiv.) in DMF (5 mL) for 5 
hours at room temp.  The resin was washed with DMF and peptide synthesis was continued as 
normal. 
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Cleavage from the resin was performed in 95:2.5:2.5 trifluoroacetic acid 
(TFA):water:triisopropylsilane (TIPS) for 4 hours.  The TFA was evaporated and products were 
precipitated with cold diethyl ether.  The peptides were extracted with water and lyophilized.  
Peptides were purified by reversed phase HPLC using a C-18 semipreparative column and a 
gradient of 0 to 100% B in 60 minutes, where solvent A was 95:5 water:acetonitrile, 0.1% TFA 
and solvent B was 95:5 acetonitrile:water, 0.1% TFA.  The purified peptides were lyophilized, 
and identity was confirmed by MALDI mass spectrometry.  Calculated: 1765 Observed: 1765.9. 
3.7.2.5 Synthesis of FAM-capped H3 3-15 
(FAM-TKQTARK(Me)3STGGKA)  Peptide containing N-terminal 5,6-carboxyfluroscein 
(FAM) was synthesized for fluorescence anisotropy using the same procedure.  Prior to cleavage 
from the resin, FAM was coupled to the N-terminus using 2 eq FAM, 2 eq PyBOP, 2 eq HOBT, 
and 4 eq DIPEA.  The coupling was bubbled with N2 overnight in a foil wrapped reaction flask 
and kept in the dark. Cleavage from the resin and purification were performed as previously 
described.  Peptide was used for experiments without desalting, and concentration was 
determined using UV-Vis absorbance of FAM at 492 nm (ε=78000 M-1cm-1). Calculated: 
[M+H+]: 1,708, [M+2H+]: 854.5, [M+3H+]: 570; Observed: [M+2H+]: 854, [M+3H+]: 570. 
3.7.3 Native Chemical Ligation Reactions   
Ligation reactions were performed in 100 mM phosphate buffer, 6 M guanidinium HCl, 
50 mM MPAA, 20 mM TCEP at pH 7, based partly on conditions from the literature.20  Buffer 
was degassed prior to use and both peptide fragments were dissolved at approximately 1 mM 
each.  The pH was adjusted back up to 7.0 after dissolving the peptides, as the TFA salts lower 
the pH.  The reactions were done at 25° C in a sealed vial.  Aliquots were taken every hour and 
quenched  by diluting the reaction 6 fold with 0.1% TFA. The reaction was analyzed by reversed 
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phase analytical HPLC using a C-18 semipreparative column and a gradient of 0 to 100% B in 
60 minutes, where solvent A was 95:5 water:acetonitrile, 0.1% TFA and solvent B was 95:5 
acetonitrile:water, 0.1% TFA.  Peaks were isolated and further analyzed by LC-MS and MALDI.  
Calculated: [M]: 6784.5, [M+5H+]: 1357.9, [M+6H+]: 1131.8, [M+7H+]: 970.2; Observed: 
[M+5H+]: 1357.2, [M+6H+]: 1131.1, [M+7H+]: 969.6. 
3.7.4 Fluorescence Anisotropy Binding Measurements  
Fluorescence anisotropy measurements were performed using a PolarStar omega plate 
reader by BMG Labtech. Chromodomain solutions of different concentrations were made by 
performing serial half dilutions of a concentrated stock. Concetration was determined by UV-Vis 
absorbance at 280 nm (ε=17780).  Chromodomain (25 µL) was added into 1 µM FAM labeled 
peptide (25 µM) in a 96 well plate in 50 mM phosphate buffer, pH 7.4, 25 mM NaCl, and 2 mM 
DTT).  Samples were allowed to equilibrate at 25° C for 30 minutes. The samples were analyzed 
using an excitation wavelength of 485 nm and an emission wavelength of 520 nm.  The data 
were analyzed in kaleidegraph using the equation: 
 
where r is fluorescence anisotropy, r0 is the anisotropy of the free histone tail, r∞ is the anisotropy 
of the fully bound histone tail, ρ is the total concentration of histone peptide, [c] is the total 
concentration of chromodomain, and Kd is the dissociation constant.  The variables r0, r∞, and Kd 
were all treated as floating variables. 
 
 
5900g, 4 8C). The cells were suspended in NiA buffer (KPO4
(50 mm), NaCl (150 mm), imidazole (5 mm), pH 8.0, 40 mL) and
were lysed with in the presence of DNAse, complete, EDTA-free
protease inhibitor cocktail (Roche Applied Sciences) and PMSF
(final concentration 1 mm). The protein was purified using Ni-NTA
resin with a step gradient of 0–250 mm imidazole using NiA and
NiB buffer (KPO4 (50 mm), NaCl (150 mm), imidazole (250 mm),
pH 8.0). The purity was confirmed by SDS-PAGE and the fractions
were pooled and dialyzed in 100-fold excess of buffer (KPO4
(50 mm), NaCl (25 m ), pH 8.0). The dialyzed protein was concen-
trated using Millipore Centricon filters (5 KDa MWCO).
Circular dichroism: CD measur ments w re performed on Aviv
62DS circular dichroism spectrometer. CD data were obtained for
the chromodomain (33.3 mm) in solution containing Na2HPO4
(10 mm), dithiothreitol (DTT, 2 mm), at pH 7.4. Wavelength scans
were performed in triplicate and averaged. Scans were performed
at 25 8C. All scans were corrected by subtracting the spectrum of
the buffer used in the experiment. The mean residue ellipticity
(MRE) was calculated from Equation (1).
V ¼ signal
10 l c
" 1
r
ð1Þ
where V is MRE, signal is CD signal, l is path length, c is protein
concentration, and r is the number of amino acid residues.
Thermal denaturation experiments were prefor ed using the same
buffer and concentrations as described above and measurements
were taken between 3 8C and 93 8C. The melting curves were nor-
malized to show the fraction folded by using Equation (2).
fraction folded ¼ ðV%VDÞ=ðVF%VDÞ ð2Þ
where V is the observed MRE, VD is the MRE for the fully dena-
tured protein, and VF is MRE for the fully folded protein.
Fluorescence anisotropy: Peptide concentrations were deter-
mined by UV/VIS using the absorbance of 5(6)-FAM (e492=
78000m%1 cm%1). Fluorescence anisotropy measurements were
taken using a PolarStar omega plate reader by BMG Labtech. Sam-
ples were pr pared by titrating chromodomain into 1 mm histone
peptides labelled with 5(6)-FAM on the N terminus in buffer (KPO4
(50 mm), NaCl (25 mm), DTT (4 mm), pH 8.0). After allowing the
samples to equilibrate for 30 min at 25 8C, they were analyzed
using an excitation wavelength of 485 nm and an emission wave-
length of 520 nm at 25 8C. The data were analyzed in Kaleidagraph
by using Equation (3). All binding curves are shown in Figures S1–
S6.
r ¼
!"
pþ ½c( þ KD )
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð%p%½c(%KDÞ2%4ðp " ½c(Þp
2p
$
" ðr1%r0Þ
%
þ r0
ð3Þ
where r is fluorescence anisotropy, r0 is the anisotropy of free his-
tone tail, r1 is the anisotropy f fully bound histon tail, p is the
total concentration of fluorescein-labeled peptide, [c] is the total
chromodomain concentration added, and KD is the dissociation
constant. The values for r0, r1, and KD were treated as floating vari-
ables.
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CHAPTER 4:  PROBING CATION-Π INTERACTIONS WITH DIFFERENT 
HISTONE SEQUENCES AND ADDITONAL NONCOVALENT INTERACTIONS 
 
4.1 Significance 
A broader understanding of the mechanism employed by reader proteins in the 
recognition of their substrates can be gained via a comparative analysis of reader proteins 
with different binding pockets, as well as the impact that other noncovalent interactions have 
on both binding and the contribution of cation-π interactions to the overall recognition.  
Reader proteins that recognize lower methylation states contain salt bridges as part of their 
recognition motif (Figure 4.1).  Others have different aromatic residues (both in number and 
type) in the binding pockets, and some have an incomplete pocket in the unbound state.  
Additionally, the contribution cation-π interactions to inhibitor binding is unknown. 
 
Figure 4.1. Binding pockets of various proteins that recognize different methylation states of 
lysine. A) PHD domain protein BHC80 binding unmethylated lysine B) MBT domain protein 
L3MBTL1 binding monomethyllysine C) Tudor domain protein 53BP1 binding 
dimethyllysine D) PHD domain protein ING2 binding Trimethyllysine. Reproduced with 
permission from Nat. Struct. Mol. Biol. 2007, 14 (11), 1025–1040. Copyright 2007 Nature 
Publishing Group.1  
 
By expanding these studies to include other reader proteins and the influence of other 
noncovalent interactions on this recognition, we can gain a broader understanding of this 
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mechanism.  Understanding the similarities and differences between different reader proteins 
will aid in the development of probes with specificities for their desired targets.2 
4.2 Reader Protein Inhibitors  
 Several inhibitors have been identified for different reader proteins, however it is 
unclear if cation-π interactions play the same role in binding inhibitors as it does in binding 
the natural substrates.  An inhibitor for the chromodomain protein CBX7 contains a 
pyrrolidinelysine while some inhibitors for KMe2 binding proteins also contain this 
pyrrolidine ring, or a tert-butyl amine (Figure 4.2).  These types of compounds, while still 
possessing a positive charge, place methyl groups or methylene groups with a smaller partial 
positive into the binding pocket than the methyl groups of methylated lysine (Figure 4.3).  It 
is possible then, that the impact of cation-π interactions of these binding events are less than 
they are with the native substrate. Other noncovalent interactions may provide more a driving 
force for this recognition.   
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Figure 4.2. Inhibitors for KMe2 reader proteins (PDB:4RG2, 3P8H).3,4 
 
Figure 4.3. Partial charges on side chain of KMe2 (left) compared to the carbons of the 
amines present in various inhibitors (center, right). 
  
4.2.1 Studying Inhibitor Interactions 
 Performing mutation studies to probe the cation-π interactions of the aromatic 
residues of binding proteins with their inhibitors in addition to the studies with their natural 
peptide substrates would provide a useful comparison of their binding mechanism.  
Additionally, these types of motifs can be incorporated in the peptide sequence to study their 
effect on the cation-π interactions with the HP1 protein, which we have already studied. 
 Efforts are currently underway to incorporate these side chains into peptides.  This 
can be done either by synthesizing unnatural residues to incorporate via solid phase peptide 
synthesis, or by performing reactions to install the side chain after peptide synthesis. 
via cation-pi interaction, but Y1500 and Y1502 contribute only weakly, and Y1523 does not contribute at all. 
Whether the cation-pi interactions are similar in magnitude, globally weaker, or dependent on the specific 
position will provide insights into strategies for developing selective inhibitors. 
Aim 3.3.  Determination of the influence of a salt bridge on a cation-pi interaction. The contribution of the 
cation-pi interaction may be perturbed by the salt bridge, as it may perturb the electrostatic potential of the 
cation. While several groups have proposed that stacking on an aromatic ring strengthens a salt bridge (in part 
by aiding in desolvation of the charged groups) (78, 79), to our knowledge, no one has asked what the impact 
of a salt bridge is on a cation-pi interaction. These studies will give new insights into whether different 
noncovalent interactions work synergistically or antagonistically, or whether a simple additivity model is 
satisfactory. We will address this by comparing two sets of mutations to L3MBTL1: one based on wild type in 
which the aromatic residues are mutated with UAAs as before, and one in which the Asp has been mutated to 
Asn, such that the charge is neutralized. L3MBTL1 will be used for this study, as mutation of D335 to Asn has 
been shown to weaken, but not obliterate binding: the binding of wild type L3MBTL1 to H4 K20Me2 is 6 uM, 
whereas the Kd is 43 uM for D355N (10). If the D1521N mutant of 53BP1 exhibits binding to one of its KMe2 
substrates, we will do the equivalent set of experiments with 53BP1. Since 53BP1 has been shown to bind P53 
K382Me2 with a Kd of 190 nM, it is likely that the D1521N mutant will indeed exhibit measurable binding (76).!
Aim 4.  Compare Mechanisms of Ligand and Inhibitor Binding via Combined Protein/Ligand SAR. 
To complement the variation of the aromatic cage, we will also vary the ligand for each of the proteins 
investigated in Aims 2 and 3 (both wild type and mutants). We will investigate (a) a neutral analog of KMe3; (b) 
unnatural cationic mimics of KMe2 and KMe3; and (c) inhibitors. A primary goal of this work is to determine 
whether other ligands rely on cation-pi interactions to the same extent as do KMe2 and KMe3, or whether 
alternative modes of binding are accessible. In all of these studies (as in previous aims) structural analysis will 
accompany binding studies to fully evaluate these systems. 
Aim 4.1. Investigate binding to a neutral analog of KMe3. Previously we 
have shown that replacing the trimethyl ammonium of KMe3 with a tert-butyl 
group (tert-butyl norleucine, tBuNle, Fig. 13) results in 30-
fold weaker binding to dHP1, amounting to a net decrease in 
binding energy of 2.2 kcal/mol, despite the much larger 
desolvation cost for KMe3 (8). This is good evidence that 
the cation-pi interaction plays an integral role in binding of 
K9Me3 to dHP1. Thus, we will investigate the binding of the 
tBuNle to the mutated aromatic cages of the KMe3 reader 
proteins, dHP1 and CBX7. While these interactions are 
expected to be weak, their binding affinities are still expected to be in the measurable 
range. Because the ligand has no charge, we do not expect to observe the same LFER 
with respect to electronic effects or calculated cation-pi interactions as was observed for 
binding of KMe3 to the Y24 mutants of HP1 (Aim 2). Substitution of EWG may have no 
effect on binding to this neutral ligand. Alternatively binding of tBuNle may actually improve 
with substituents that effectively neutralize the partial charge on the face of the ring, as can 
be seen with the addition of three fluorines or one nitro group (Fig. 14).  
Aim 4.2.  Investigation of binding to unnatural charged mimics of 
KMe2 and KMe3. Compounds containing pyrrolidines and tert-
butylamines (Fig. 15) have been found to be successful binding 
elements for replacing KMe2 in inhibitors of some KMe2 readers, 
discovered by the Frye group at UNC (13, 14). Crystal structures of both 
of these probes to their target proteins indicate that the pyrrolidine ring or 
tBu group sits in the aromatic cage and the NH makes an H-bond with 
an Asp side chain in the binding pocket. In each case, a larger alkyl 
group is accommodated in the KMe2 binding pocket. The beta-
methylenes in pyrrolidine and the tBu group in tBu-amines have a 
smaller partial positive charge on the alkyl groups than do the methyl 
groups in KMe2 as calculated using Spartan (see Fig. 16), such that the 
cation-pi interaction between the aromatic cage and the pyrrolidine or 
tert-butylamine is expected to be weaker. We will test this hypothesis by 
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Figure. 15.  Inhibitors for KMe2 reader 
proteins 53BP1 and L3MBTL1. 
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via cation-pi interaction, but Y1500 and Y1502 contribute only weakly, and Y1523 does not contribute at all. 
Whether he cation-pi nteractions are similar in magnitude, globally weaker, or d pendent on the specific 
po tion will provide n ights into strategies for developing selective inhibitors. 
Aim 3.3.  Determination of the influence of a salt br dge on a cation-pi i teraction. The contribution of the 
cation-pi interaction may be perturbed by the salt bridge, as it may perturb the e ectrostatic potential of the 
cation. W ile several groups have proposed that sta king on a  aromatic ring strengthens a salt bridge (in part 
by aiding in desolvation of the charged groups) (78, 79), to our knowledge, no one has sked what the impact 
of a salt bridge is on a cation-pi interaction. Thes  studies will give new ins ghts into whether different 
n covalent i teractions work synergistically antagonistically, or whether a simple additivity model is 
s tisfactory. We will address this by comparing two sets of mutations to L3MBTL1: on based on wild type in 
which the aro atic residues are mutated with UAAs as before, and one in which the Asp has been mutated to 
Asn, such that the charge is neutraliz d. L3MBTL1 will be u ed for this study, as mutation of D335 to Asn has 
b en shown to we k n, but no  obliterate binding: th  binding of wild type L3MBTL1 to H4 K20Me2 is 6 uM, 
whereas the Kd is 43 uM for D355  (10). If the D1521N mutant of 53BP1 exhibits binding to one of its KMe2 
substrates, w  will do the equivalent set of experiments with 53BP1. Si ce 53BP1 has been shown to bind P53 
K382Me2 w h a Kd of 190 nM, it is likely that the D1521N mutant will indeed exhibit measurable binding (76).!
Aim 4.  Compare Mech isms of Liga  and Inhibitor Binding via Combined Protein/Ligand SAR. 
To complement the v riation of the aromatic cage, we will also vary the ligand for each of the proteins 
investigated in Aims 2 and 3 (bo h wild type and mutants). We will investigate (a) a n utral analog of KMe3; (b) 
unnatural cationic mimics of KMe2 and KMe3; and (c) inhibit rs. A primary goal of th s work is to determine 
whether other ligands rely on cation-pi interactio s to the same extent as do KMe2 and KMe3, or whether 
alternative modes of indi g are accessible. In all of these studies (a  in previous aim ) structural analysis will 
accompany binding studies to fully valuate these systems. 
Aim 4.1. Investigate binding t  a neutral analog of KMe3. Previously we 
h ve shown that replacing the trimethyl ammonium of KMe3 with a tert-butyl 
group (tert-butyl norleucin , tBuNle, Fig. 13) results in 30-
fold weaker binding to dHP1, amounting to a net decrease in 
binding energy of 2.2 kcal/mo , despite the much larger 
desolvation co t for KMe3 (8). This is good evidence that 
he cation-pi interaction plays an integral role in binding of 
K9Me3 to dHP1. Thus, we will vestigate the binding of the 
tBuNle to the mutated aromatic cages of the KMe3 reader 
proteins, dHP1 and CBX7. While these interactions are 
expected to be weak, thei  binding affinities ar still xp cted to be in the measurable 
range. Because the ligand has no charge, we do no  expect to observe the same LFER 
with respect t  electronic effects or calcula ed cation-pi interactions as was observed for 
binding of KMe3 to the Y24 utants of HP1 (Aim 2). Substitution of EWG may have no 
effect on binding to this eutral ligand. Alternativ ly binding of tBuNle may actually improve 
with substituents that ffectively neutralize the partial charge on the f ce of the ring, as can 
be seen with the addition of three fluorines or one nitro group (Fig. 14).  
Aim 4.2.  Investigation of binding to unnatural charged mimics of 
KMe2 a  KMe3. Compounds containing pyrrolidines and tert-
butylamines (Fig. 15) have be n found to be successful binding 
elements for replacing KMe2 in inhibitors of ome KMe2 readers, 
discovered by the Frye group at UNC (13, 14). Crystal structures of both 
of these probes to their target prot ins indicat  that the pyrrolidine ring or 
tBu group sits in the aromatic cage d the NH makes an H-bond with 
an Asp side chain in the binding pocket. In each case, a larger alkyl 
group is accommodated in the KMe2 binding pocket. The beta-
methylenes in pyrrolidine and the tBu group in tBu-amines have a 
smaller partial positive charge on the alkyl groups than do the methyl 
groups in KMe2 as calculat d using Spartan (see Fig. 16), such that the 
cation-pi int r ction betwe n the aromatic cag  and the pyrrolidine or 
tert-butylamine is expect d to be weaker. We will test this hypothesis by 
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via cation-pi interaction, but Y1500 and Y1502 contribute only weakly, and Y1523 does not contribute at all. 
Whether the cation-pi interactions are similar in magnitude, globally weaker, or dependent on the specific 
position will provide insights into strategies for developing selective inhibitors. 
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cation-pi interaction may be perturbed by the salt bridge, as it may perturb the electrostatic potential of the 
cation. While sever l groups hav  proposed that stacking on an aromatic ring strengthens a salt bridge (in part 
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substrates, we will do t e equivalent set of experiments with 53BP1. Since 53BP1 has been shown to bind P53 
K382Me2 with a Kd of 190 nM, it is likely that the D1521N mutant will indeed exhibit measurable binding (76).!
Aim 4.  Compare Mechanisms of Ligand and Inhibitor Binding via Combined Protein/Ligand SAR. 
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with r sp ct to electronic effects or calculated cation-pi interactions as was observed for 
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be seen with the addition of three fluorines or one nitro group (Fig. 14).  
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KMe2 and KMe3. Compounds containing pyrrolidines and tert-
butylamines (Fig. 15) have been found to be successful binding 
elements for replacing KMe2 in inhibitors of some KMe2 readers, 
discovered by the Frye group at UNC (13, 14). Crystal structures of both 
of these probes to their target proteins indicate that the pyrrolidine ring or 
tBu group sits in the aromatic cage and the NH makes an H-bond with 
an Asp side chain in the binding pocket. In each case, a larger alkyl 
group is accommodated in the KMe2 binding pocket. The beta-
methylenes in pyrrolidine and the tBu group in tBu-amines have a 
smaller partial positive charge on the alkyl groups than do the methyl 
groups in KMe2 as calculated using Spartan (see Fig. 16), such that the 
cation-pi interaction between the aromatic cage and the pyrrolidine or 
tert-butylamine is expected to be weaker. We will test this hypothesis by 
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 One approach allowing for rapid synthesis of many different side chain mimics 
involves the use of the thiol nucleophile by incorporating a cysteine at the desired location.  
This cysteine can then be reacted with a variety of electrophiles to install a mimic of some of 
these side chains (Figure 4.4).   
  
Figure 4.4.  Approach for rapidly synthesizing peptides with a variety of side chain mimics, 
using cysteine mutation. 
 
This method has been shown to be successful in mimicking various post translational 
modifications in proteins, such as acetylated lysine, as well as mono- di- and 
trimethyllysine.5–7  By using pH control, alkylation can be done at cysteine, while avoiding 
reaction with amine nucleophiles that may also be present, providing a good way to achieve 
site selective incorporation of the modification.5 This approach provides a rapid way to 
mimic some of the structural motifs found in inhibitors, and can provide an initial screen for 
their impact on the cation-π interactions with reader proteins. 
4.3 Salt Bridges in Reader Proteins 
 While reader proteins of lower methylation states still have an aromatic cage to 
recognize the cation, a carboxylic acid is generally found in the binding pocket to form a salt-
bridge with the NH groups in lower methylation states of Lys.  For example, HP1 also 
recognizes dimethyllysine and contains a glutamic acid that forms a water mediated salt 
bridge with KMe2 in the binding pocket in addition to the cation-π interactions with the 
aromatic residues (Figure 4.5).   
HS
Br R
S
R
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Figure 4.5. HP1 bound with KMe2 peptide containing a water-mediated salt bridge (shown in 
yellow) between E52 and KMe2. (PDB: 1KNA). 8 
 
4.3.1 E52Q Mutation of HP1 
Previous studies by our lab have shown how important this salt bridge is for the 
recognition of dimethyllysine by the HP1 chromodomain.  By replacing the glutamic acid 
with a glutamine, which contains an amide, the ability for the residue to hydrogen bond is 
reduced, and the charge needed for an electrostatic interaction is removed (Figure 4.6). 
 
E52 
! 110 
 
Figure 4.6. Glutamic acid (left) and glutamine (right). 
Mutation of the carboxylic acid to the amide in the E52Q mutation does not reduce the ability 
of the protein to recognize trimethyllysine.  However, the affinity for dimethyllysine is 
reduced approximately two-fold (Table 4.1).9 
Table 4.1. Dissociation constants of E25Q mutant with di- and trimethyllysine 
Protein K(Me)3 Kd (uM) K(Me)2 Kd (uM) 
Wild Type 17 20 
E52Q 15 52 
 
 Electrostatics do not play a role in the binding of KMe3 as there is no chance from 
WT HP1.  However, the carboxylic acid is important for the water mediated hydrogen bond 
in the recognition of KMe2.  With this added interaction, it is unknown whether cation-π 
interactions still play a similar role in the recognition of the lower methylation state. These 
interactions can be probed by mutating the binding pocket aromatics with electron 
withdrawing residues and measuring the effect on binding to dimethyllysine and compared to 
the trimethyllysine studies already done (Chapter 2).  By using surface plasmon resonance 
(SPR) to measure these binding interactions, multiple peptides can be studied within a short 
period of time, as protein is loaded onto a chip with peptide flowed over to measure binding.  
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Binding studies with trimethyllysine containing peptide can be followed up with 
dimethyllysine containing peptide with the same proteins to further insure the results can be 
compared directly do each other.  Initial work is underway to synthesize analogous peptides 
containing dimethyllysine for these studies. 
4.4 Binding Neutral Analogs 
 An approach that has been used numerous times to probe cation-π interactions is the 
replacement of the cation with a neutral analog.  It has already been shown by work done in 
our lab that binding of HP1 to histone peptide containing a tert-butyl analog of 
trimethyllysine significantly reduces the binding affinity (Figure 4.7).10  
 
Figure 4.7. Neutral analog of trimethyllyinse used to probe cation-π interactions. 
4.4.1 Neutral Analog and E52Q Mutant  
This neutral analog can be further used to study the role of the carboxylic acid in the 
binding of trimethyllysine.  As the E52Q mutant does not show a reduced binding to 
trimethyllyine, and electrostatics are not thought to play a role in the recognition of KMe3, 
however, the electrostatics may have contributed to the weakened binding observed between 
HP1 and the neutral tert-butyl group. In the E52Q mutatnt, this repulsion is relieved, and it is 
possible the tert-butyl group will bind more strongly to the mutant than the WT protein. This 
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will provide more insight into the contribution of reduced cation-π interactions as apposed to 
potential added negative electrostatic interactions upon binding to the neutral side chain. 
 Stef Baril in the Brustad lab successfully expressed this mutant for binding studies.  
Initally, binding measurements were done by fluorescence anisotropy of wild type HP1 
chromodomain (Figure 4.8) and the E52Q mutant (Figure 4.9) with H3K9Me3 peptide to 
verify we could repeat the results that had been previously reported.9  These experiments, 
however, measured a binding affinity of 38 µM for WT and 76 µM for E52Q, which were not 
only different from each other, but also different from those reported in the literature and 
measured previously by us.  We again determined that anisotropy was giving inconsistent 
results, and further experiments will be carried out using isothermal titration calorimetry 
(ITC) or SPR, which has been shown to be more reliable for measuring binding affinities 
with our HP1 mutants. 
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Figure 4.8. Binding curve of Wild Type HP1 titrated into FAM labeled H3K9Me3 peptide 
(FAM-TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate buffer, pH 8, 25 nM NaCl, 
2 mM DTT. 
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Figure 4.9. Binding curve of E52Q HP1 titrated into FAM labeled H3K9Me3 peptide (FAM-
TKQTARK(Me)3STGGKA – 1 µM) in 50 mM phosphate buffer, pH 8, 25 nM NaCl, 2 mM 
DTT. 
 
4.4.2 Neutral Analog and HP1 Mutants 
 
 Binding of the neutral analog with the mutated binding pockets of HP1 can also be 
analyzed.  As SPR allows for easily studying the proteins loaded on the chip with multiple 
peptide ligands, this method will be useful for these experiments as well.  Because there is no 
cation, it is not expected that this residue will exhibit the same linear free energy 
relationships that are observed upon binding of the mutants to trimethyllysine.  It is possible 
that the mutations have no effect on binding.  Alternatively, the binding may actually 
increase with the neutralization of the partial negative on the face of the ring. We will 
determine whether any trend exists with hydrophobicity or polarizability of the mutants as 
well. 
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4.4.3 Neutral Analog and Other Reader Proteins  
Lastly, the neutral analog can be used to probe a variety of reader proteins.  In 
addition to the work with HP1, this approach has been used with several other reader 
proteins, with some of them resulting in a similar drop in affinity to that observed with HP1, 
but not all, indicating a potential different recognition mechanism.11  The Frye lab at UNC 
has a variety of proteins that can be screened with various peptides for binding (Table 4.2) 
Table 4.2. Reader proteins the sequence of peptides they bind to. 
Protein Peptide Peptide sequence 
53BP1 H4K20Me2 KGGAKRHRK(Me2)VLRDNIQ-OH 
L3MBTL1 H4K20Me1 KGGAKRHRK(Me1)VLRDNIQ-OH 
L3MBTL3 H4K20Me2 KGGAKRHRK(Me2)VLRDNIQ-OH 
MBTD1 H4K20Me1 KGGAKRHRK(Me1)VLRDNIQ-OH 
CBX7 H3K9Me3 ARTKQTARK(Me3)STGGKAPRKQL-NH2  
UHRF1 H3K9Me3 ARTKQTARK(Me3)STGGKAPRKQL- NH2  
PHF23 H3K4Me3 ARTK(Me3)QTARKSTGGKAPRKQYT- NH2  
JARID1A H3K4Me3 ARTK(Me3)QTARKSTGGKAPRKQYT- NH2  
PHF1 H3K36Me3 KSAPSTGGVK(Me3)KPHRYRPGTV- NH2 
PHF19 H3K36Me3 KSAPSTGGVK(Me3)KPHRYRPGTV- NH2 
 
The binding of these proteins can be studied with the replacement of the natural 
sequence with one containing the neutral analog.  This would give a broader comparison 
across reader proteins, and reveal any potential different binding mechanisms.  Potential 
differences between readers of trimethyllysine and lower methylation states can also be 
revealed.  Initial peptide synthesis has been unsuccessful, as complex mixtures that are 
difficult to purify are often formed during synthesis of these longer histone sequences.  While 
optimizing conditions for histone sequence synthesis, automated methylation of 
dimethyllysine was developed for a microwave peptide synthesizer. 
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4.5 Experimental 
4.5.1 Peptide Synthesis 
4.5.1.1 Synthesis of H3 1-15 K9Me2   
H3 1-15 containing KMe3 at position 9 (ARTKQTARK(Me)2STGGKAY) was 
synthesized by hand using Fmoc protected amino acids and Rink Amide resin on a 0.06 
mmol scale.  The amino acid residues were activated with HBTU (O-benzotriazole-N, N, N’, 
N’,-tetramethyluronium hexafluorophosphate) and HOBT (N-hydroxybenzotriazole) in the 
presence DIPEA (diisopropylethylamine) in  DMF (N,N-dimethylformamide).  Double 
couplings of 30 minutes each were used.  Deprotections were carried out in 20% piperidine 
in DMF, twice for 15 minutes each.  
 Dimethyllysine was coupled using 2 equivalents of Fmoc-Lys(Me)2-OH HCl for 5 
hours.  The resin was washed with DMF and peptide synthesis was continued as normal. 
Cleavage from the resin was performed in 95:2.5:2.5 trifluoroacetic acid 
(TFA):water:triisopropylsilane (TIPS) for 4 hours.  The TFA was evaporated and products 
were precipitated with cold diethyl ether.  The peptides were extracted with water and 
lyophilized.  The peptide was purified by reversed phase HPLC using a C-18 semipreparative 
column and a gradient of 0 to 100% B in 60 minutes, where solvent A was 95:5 
water:acetonitrile, 0.1% TFA and solvent B was 95:5 acetonitrile:water, 0.1% TFA.  HPLC 
traces were complex, and complete purification was difficult.  After 3 purifications, 
impurities remained, and the peptide was not fully purified. The peptide was lyophilized, and 
identity was confirmed by MALDI mass spectrometry. Calculated: 1751 Observed: 1752.6 
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4.5.1.2 Synthesis of FAM-capped Peptides  
 H3K9Me3 peptide (residues 3-15) containing N-terminal 5,6-carboxyfluroscein 
(FAM) (FAM-TKQTARK(Me)3STGGKA) was synthesized for fluorescence anisotropy 
using the same procedure.  After coupling of dimethyllysine, the resin was washed with DMF 
and the residue was methylated to form trimethyllysine with 7-methyl- 1,5,7-triaza-
bicyclo[4.4.0]dec-5-ene  (MTDB, 10.8 uL, 0.075 mmol) and methyl iodide (37.4 uL, 0.6 
mmol) in DMF (5mL) for 5 hours at room temperature.  Peptide synthesis was then 
continued to finish the sequence.  Prior to cleavage from the resin, FAM was coupled to the 
N-terminus using 2 eq FAM, 2 eq PyBOP, 2 eq HOBT, and 4 eq DIPEA.  The coupling was 
bubbled with N2 overnight in a foil wrapped reaction flask and kept in the dark. Cleavage 
from the resin and purification were performed as previously described. Peptide was 
confirmed by ESI-MS. Calculated: [M+] 1,733, [M++H+]: 867, [M++2H+]: 578.33  Observed: 
[M++H+]: 866.9,  [M++2H+]: 578.39. 
4.5.1.3 Synthesis of KMe3 and Microwave Methylation  
H3K9Me3 peptide (ARTKQTARKSTGGKAY) was synthesized on a CEM Liberty1 
Microwave Peptide Synthesizer using Fmoc protected amino acids and Rink Amide resin. 
The amino acid residues (5 eq) were activated with DIC (diisopropylcarbodiimide, 5 eq)) in 
the presence of Oxyma (Ethyl (hydroxyimino)cyanoacetate, 5 eq).  Double couplings of 4 
minutes each at 90 °C were used.  Arginine and histidine residues were coupled at RT for 4 
min and 50 °C for 8 min. Deprotections were carried out in 10% piperazine and 0.1 HOBt 
(hydroxy benzyl triazole) in 9:1 NMP:EtOH, twice for 60 seconds each at 90 °C.  Coupling 
of Fmoc-Lys(Me)2-OH HCl was performed for 5 hours at room temperature and injected 
using a plastic insert containing the unnatural amino acid in place of an unused amino acid 
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bottle.  Methylation immediately followed coupling, and was performed by placing the 
methylation solution (7-methyl- 1,5,7-triaza-bicyclo[4.4.0]dec-5-ene  (MTDB, 10.8 uL, 
0.075 mmol) and methyl iodide (37.4 uL, 0.6 mmol) in 2.5 mL DMF) at an amino acid 
position and running a coupling method without the injection of coupling reagents. The 
methylation was performed for 5 hours at room temperature.  Coupling steps as normal 
continued after methylation.  Cleavage and purification were performed as previously 
described. Peptide characterized by MALDI. Calculated: 1765 Observed: 1765.9. 
4.5.2 Fluorescence Anisotropy Binding Experiments 
Fluorescence anisotropy measurements were performed using a PolarStar omega plate reader 
from BMG Labtech. Chromodomain solutions of different concentrations were made by 
performing serial half dilutions of a concentrated stock.  Concentrations were determined by 
UV-Vis absorbance at 280 nm (ε=17780). Chromodomain (25 µL) was added into 1 µM 
FAM labeled peptide (25 µM) in a 96 well plate in 50 mM phosphate buffer, pH 7.4, 25 mM 
NaCl, and 2 mM DTT).  Samples were allowed to equilibrate at 25 °C for 30 minutes. The 
samples were analyzed using an excitation wavelength of 485 nm and an emission 
wavelength of 520 nm.  The data were analyzed in Kaleidegraph using the equation: 
 
 
where r is fluorescence anisotropy, r0 is the anisotropy of the free histone tail, r∞ is the 
anisotropy of the fully bound histone tail, ρ is the total concentration of histone peptide, [c] is 
the total concentration of chromodomain, and Kd is the dissociation constant.  The variables 
r0, r∞, and Kd were all treated as floating variables. 
 
5900g, 4 8C). The cells were suspended in NiA buffer (KPO4
(50 mm), NaCl (150 mm), imidazole (5 mm), pH 8.0, 40 mL) and
were lysed with in the presence of DNAse, complete, EDTA-free
protease inhibitor cocktail (Roche Applied Sciences) and PMSF
(final concentration 1 mm). The protein was purified using Ni-NTA
resin with a step gradient of 0–250 mm imidazole using NiA and
NiB buffer (KPO4 (50 mm), NaCl (150 mm), imidazole (250 mm),
pH 8.0). The purity was confirmed by SDS-PAGE and the fractions
were pooled and dialyzed in 100-fold excess of buffer (KPO4
(50 mm), NaCl (25 mm), pH 8.0). The dialyzed protein was concen-
trated using Millipore Centricon filters (5 KDa MWCO).
Circular dichroism: CD measurements were performed on an Aviv
62DS circular dichroism spectrometer. CD data were obtained for
the chromodomain (33.3 mm) in solution containing Na2HPO4
(10 mm), dithiothreitol (DTT, 2 mm), at pH 7.4. Wavelength scans
wer performed in triplicate and averag d. Scans were performed
at 25 8C. All scans were corrected by subtracting the spectrum of
the buffer used in the experiment. The mean residue ellipticity
(MRE) was calculated from Equation (1).
V ¼ signal
10 l c
" 1
r
ð1Þ
where V is MRE, signal is CD signal, l is path length, c is protein
concentration, and r is the number of amino acid residues.
Thermal denaturation experiments were preformed using the same
buffer and concentrations as described above and measurements
were taken between 3 8C and 93 8C. The melting curves were nor-
malized to show the fraction folded by using Equation (2).
fraction folded ¼ ðV%VDÞ=ðVF%VDÞ ð2Þ
where V is the observed MRE, VD is the MRE for the fully dena-
tured protein, and VF is MRE for the fully folded protein.
Fluorescence anisotropy: Peptide concentrations were deter-
mined by UV/VIS using the absorbance of 5(6)-FAM (e492=
78000m%1 cm%1). Fluorescence anisotropy measurements were
taken using a PolarStar omega plate reader by BMG Labtech. Sam-
ples were prepared by titrating chromodomain into 1 mm histone
peptides labelled with 5(6)-FAM on the N terminus in buffer (KPO4
(50 mm), NaCl (25 mm), DTT (4 mm), pH 8.0). After allowing the
samples to equilibrate for 30 min at 25 8C, they were analyzed
using an excitation wavelength of 485 nm and an emission wave-
length of 520 nm at 25 8C. The data were analyzed in Kaleidagraph
by using Equation (3). All binding curves are shown in Figures S1–
S6.
r ¼
!"
pþ ½c( þ KD )
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃð%p%½c(%KDÞ2%4ðp " ½c(Þp
2p
$
" ðr1%r0Þ
%
þ r0
ð3Þ
where r is fluorescence anisotropy, 0 is the anisotropy of free his-
tone tail, r1 is the anisotropy of fully bound histone tail, p is the
total concentration of fluorescein-labeled peptide, [c] is the total
chromodomain concentration added, and KD is the dissociation
constant. The values for r0, r1, and KD were treated as floating vari-
ables.
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